WO2017000089A1 - Biotechnological breeding method for obtaining antiviral seedless grapes - Google Patents

Biotechnological breeding method for obtaining antiviral seedless grapes Download PDF

Info

Publication number
WO2017000089A1
WO2017000089A1 PCT/CN2015/000519 CN2015000519W WO2017000089A1 WO 2017000089 A1 WO2017000089 A1 WO 2017000089A1 CN 2015000519 W CN2015000519 W CN 2015000519W WO 2017000089 A1 WO2017000089 A1 WO 2017000089A1
Authority
WO
WIPO (PCT)
Prior art keywords
medium
antiviral
embryo
grape
seedless
Prior art date
Application number
PCT/CN2015/000519
Other languages
French (fr)
Chinese (zh)
Inventor
田莉莉
牛良
Original Assignee
中国农业科学院郑州果树研究所
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 中国农业科学院郑州果树研究所 filed Critical 中国农业科学院郑州果树研究所
Publication of WO2017000089A1 publication Critical patent/WO2017000089A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8283Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01HNEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H4/00Plant reproduction by tissue culture techniques ; Tissue culture techniques therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression

Definitions

  • the invention belongs to the technical field of agricultural biotechnology breeding, and particularly relates to a biotechnology breeding method for obtaining antiviral seedless grapes.
  • Grape is one of the oldest fruit tree species in the world. It is popular among domestic and foreign consumers for its succulent, nutritious and multi-health functions. In recent years, the demand for table grape varieties in the domestic and foreign markets has also come. The higher, especially the non-nuclear grapes are more and more popular, and the existing seedless grape varieties can no longer meet the production needs. At the same time, grapes are also the most fruit species of the virus species [Martelli et al. Grapevine virology highlights: 2010-2012. Proceedings of the 17th Congress of ICVG, Davis, Califomia, USA, 2012: 13-31]. In recent years, grapes have been developed in various parts of China, and introductions have been frequent between regions.
  • RNAi vectors constructed by transforming all or part of the viral coat protein gene can obtain disease-resistant transgenic plants [Zhu Changxiang et al. Cultivation of PVY, TMV and CMV Transgenic Tobacco. China Agricultural Sciences, 2008, 41(4): 1040-1047].
  • RNAi vectors Most researchers in the construction of RNAi vectors usually select relatively conserved fragments in the viral genome as interference fragments, which can also reduce the loss of disease resistance of transgenic plants caused by viral mutations [Xu et al. conserved sequences of replicas gene- Mediated resistance to Potyvirus through RNA silencing. Journal of Plant Biology, 2009, 52(6): 550-559].
  • the commonly used method of embryo rescue technology to cultivate seedless grape has some inadequacies: most of the non-nuclear grapes cultivated in production belong to the Eurasian species, although the quality is good but the disease resistance is generally poor. It is easy to obtain “nuclear-free ⁇ non-nuclear” non-nuclear offspring, but the obtained non-nuclear grapes are often less resistant to disease than the parents, and are more vulnerable to various viruses in nature. Therefore, relying solely on embryos to save this single organism The non-nuclear grapes obtained by technical means have great defects in antiviral diseases.
  • the object of the present invention is to provide a biotechnology breeding method for obtaining antiviral seedless grape.
  • the embryo rescue technology and the transgenic two biotechnology methods are organically fused in the non-nuclear grape hybrid embryo.
  • the embryoid body induced by the zygotic embryo with the non-nuclear gene is used as a transgenic receptor material, and an RNAi antiviral vector containing the viral coat protein gene is introduced to obtain an antiviral disease.
  • Nuclear grape regeneration plant new material is used.
  • the technical solution adopted by the invention is a biotechnology breeding method for obtaining antiviral seedless grapes, comprising the following steps:
  • Step 1 Obtaining a grape zygotic embryo with a non-nuclear gene by crossing between the seedless grape varieties and embryo rescue;
  • Step 2 Inducing the growth of grape somatic embryos by zygotic embryos
  • Step 3 Construct an RNAi antiviral plant expression vector and transfer it to Agrobacterium tumefaciens;
  • Step 4 Agrobacterium transforms the somatic embryo derived from the zygotic embryo to obtain a regenerated plant.
  • the invention also features:
  • step 1 the grape zygotic embryo with the non-nuclear gene obtained by hybridization and embryo rescue of the seedless grape variety is specifically:
  • Step 1.1 Artificial emasculation of the female parent species 3 days before flowering, the inflorescences after emasculation are immediately sprayed clean with water and bagged and tagged;
  • Step 1.2 On the 2-3rd day after the emasculation, the father's pollen is collected by the brush and scattered on the stigma of the female parent for artificial pollination;
  • Step 1.3 After 6 weeks of pollination, the young fruit was collected in the field, rinsed with tap water for 10 min; soaked in 70% alcohol for 1 minute on the ultra-clean workbench, then immersed in 0.1% HgCl 2 for 8 minutes, rinsed 4 times with sterile water. ;
  • Step 1.4 The sterilized fruit pieces are placed in a sterilized culture dish, and the ovules are taken out under aseptic conditions, and inoculated on the zygotic embryo development medium for ovule endogenous culture, and the zygotic embryo development medium is solid-liquid two-phase. TL medium;
  • Step 1.5 After the ovule is cultured on the zygotic embryo development medium for 6 weeks, the developing immature embryos are taken out under aseptic conditions, and inoculated on the solid embryogenic callus induction medium; that is, the grape zygotic embryo with the non-nuclear gene is obtained. .
  • composition and content of TL medium are as follows: calcium nitrate 250.0 mg / L, potassium nitrate 600.0 mg / L, potassium chloride 75.0 mg / L, ammonium nitrate 300.0 mg / L, magnesium sulfate 1200.0 mg / L, potassium dihydrogen phosphate 300.0mg/L, manganese sulfate 3.0mg/L, potassium iodide 0.8mg/L, boric acid 0.5mg/L, zinc sulfate 0.5mg/L, sodium selenite 0.25mg/L, cobalt chloride 0.025mg/L, copper sulfate 0.025mg/L, sodium molybdate 0.025mg/L, ferric citrate 10.0mg/L, thiamine hydrochloride 0.25mg/L, pyridoxine hydrochloride 0.25mg/L, D-pantothenate 0.25mg/L, nicotinic acid 0.25m
  • step 2 the somatic embryos induced by zygotic embryos are specifically:
  • Step 2.1 inoculation of the hybrid zygotic embryo obtained in step 1 on a solid embryogenic callus induction medium
  • Step 2.2 After the zygotic embryo is cultured on the embryogenic callus induction medium for 4 weeks, the obtained yellow, granular, and compact embryogenic callus is inoculated on the solid somatic embryo differentiation medium;
  • Step 2.3 After the embryogenic callus is cultured on the somatic embryo differentiation medium for 4 weeks, a large number of somatic embryos can be induced, and at this time, most somatic embryo development stages are in the cotyledon stage.
  • the composition of the embryogenic callus induction medium in step 2.1 is TL+0.5mg/L6-BA+1.0mg/L 2,4-D, wherein sucrose 30g/L and agar 6.0g/L are added; step 2.3
  • the composition of the medium somatic embryo differentiation medium was TL+0.5 mg/L 6-BA+2.0 mg/L NAA, wherein 30 g/L of sucrose and 6.0 g/L of agar were added.
  • RNAi antiviral plant expression vector is constructed in step 3 and transferred to Agrobacterium tumefaciens:
  • RNAi interference fragment GV is GFLV, GLRaV-3, GVA and GVB
  • SEQ ID NO. 1 The 825 bp large fragment obtained by sequential concatenation of the four grape virus coat protein genes was sequenced in SEQ ID NO. 1; PCR amplification was carried out with GV upstream primer GV-F and downstream primer GV-R added with linker CACC. The PCR product was subjected to 1.0% agarose gel electrophoresis and the target band was cut and recovered to obtain the blunt-end PCR product containing the interference fragment GV; 6 ⁇ L of the ligation reaction system was constructed, and the reaction was carried out at 25 ° C for 30 min, and the product was transformed by heat shock method.
  • Step 3.2 Construction of RNAi vector: LR reaction of the entry vector pENTR-GV and the target vector pHELLSGATE12 to construct a 20 ⁇ L LR reaction system; after reacting at 25 ° C for 12 h, the reaction was terminated by adding proteinase K; the reaction product was heat-transformed into E. coli Top10 Competent cells were uniformly coated on LB medium plates containing 100 mg/L spectinomycin (Spec), inverted culture at 37 ° C for 16 h, and monoclonal cloned into LB liquid medium containing the same concentration of Spec in shaking culture at 37 ° C for 14 h.
  • Spec spectinomycin
  • the plasmid was digested with Xho I and Xba I, and the pHELLSGATE12 was used as a control.
  • the recombinant plasmid after LR reaction was digested with Xho I and Xba I, and the fragment size was 917 bp and 915 bp, respectively.
  • the recombinant plasmid was constructed as RNAi vector and named PH12- GV;
  • Step 3.3 RNAi vector transformation Agrobacterium tumefaciens: The PH12-GV vector was transformed into Agrobacterium strain EHA105 competent cells, and uniformly coated on YEB plate medium containing 50 mg/L rifampicin and 100 mg/L spectinomycin, 28 Incubate for 48 h under °C conditions, pick the monoclonal to the same concentration of rifampicin and spectinomycin in YEB liquid medium for 28 h at 28 °C, and use GV-F and GV-R as primers for PCR amplification. After electrophoresis on a 1.0% agarose gel, the PCR product was a 829 bp fragment, and the RNAi plant expression vector engineering strain was transformed and named EH-GV.
  • the sequence of the GV-F upstream primer GV-F is shown in SEQ ID NO. 2, specifically: CACCATGGGTGATGAGCTTTGATGC; the sequence of the downstream primer of the GV is shown in SEQ ID NO. 3, specifically: TAGACTCTCAAGCTTGCTAA;
  • the PCR reaction system in step 3.1 and step 3.3 is: 10 ⁇ Buffer 5 ⁇ L, dNTP mixtuer 5 ⁇ L, 10 ⁇ mol/L GV-F 2 ⁇ L, 10 ⁇ mol/L GV-R 2 ⁇ L, Pfu DNA Polymerase 1 ⁇ L, template 1 ⁇ L, sterilization double 34 ⁇ L of distilled water, the total volume of 50 ⁇ L; PCR reaction parameters: pre-denaturation at 94 °C for 5min; denaturation at 94 °C for 30s, annealing at 56 °C for 30s, extension at 72 °C for 40s, a total of 35 cycles; 72 °C extension for 10min;
  • M13-F The sequence of M13-F is shown in SEQ ID NO. 4, specifically: GTAAAACGACGGCCAGT.
  • the ligation reaction system used in step 3.1 is: recovery of the target gene fragment GV 1 ⁇ L, salt solution 1 ⁇ L, pENTR TM /SD/ Vector 1 ⁇ L, 3 ⁇ L of sterile ultrapure water.
  • the Xba I digestion system in step 3.2 is: Xba I 1 ⁇ L, 10 ⁇ M Buffer 2 ⁇ L, 0.1% BSA 2 ⁇ L, LR reaction product 6 ⁇ L, sterile ultrapure water 9 ⁇ L;
  • Xho I digestion system Xho I 1 ⁇ L, 10 ⁇ H Buffer 2 ⁇ L, LR reaction product 6 ⁇ L, and sterile ultrapure water 11 ⁇ L.
  • the LR reaction system in the step 3.2 was: pENTR-GV 2 ⁇ L, pHELLSGATE 12, 2 ⁇ L, LR clonase enzyme mix 4 ⁇ L; Sterile water 12 ⁇ L.
  • step 4 the Agrobacterium-derived zygotic embryo-derived somatic embryos obtain regenerated plants as follows:
  • Step 4.1 at 28 ° C, 200 rpm, the RNAi plant expression vector engineering strain EH-GV transformed with Agrobacterium was shake cultured in YEB liquid medium containing 50 mg/L rifampicin for 48 hours until the OD value was about 0.5. After centrifugation at 5000 rpm for 10 minutes, the precipitated cells were collected, resuspended in an equal volume of WPM liquid medium, and the somatic embryo obtained in step 2.3 was inoculated with Agrobacterium liquid for 10-15 minutes;
  • Step 4.2 The infected somatic embryo is placed in a sterile culture dish, and the excess bacterial solution is blotted with the sterile filter paper, inoculated on the WPM solid medium, and cultured for 3 days in the dark;
  • Step 4.3 after inoculation of the infected somatic embryos in WPM + 0.2 mg / L 6 - BA + 50 mg / L kanamycin (Kan) + 200 mg / L cephalosporin (Cef) + 200 mg / L carbenicillin (Carb) medium, cultured for 3 months under the conditions of 16h/8h photoperiod, once every 2 weeks;
  • Step 4.4 cultivating the resistant bud obtained by germination on 1/2MS+0.2mg/L ⁇ butyric acid (IBA)+25mg/L Kan+200mg/L Cef+200mg/L Carb medium at 16h/8h light Incubate for 2 months under cyclic conditions, subculture every 4 weeks, and the tube seedlings after rooting are expanded on 1/2MS+0.2mg/L IBA+25mg/L Kan+200mg/L Cef+200mg/L Carb medium. Regenerated plants with strong growth and good rooting are cultivated and transplanted in the greenhouse to prepare antiviral seedless grapes.
  • IBA 1/2MS+0.2mg/L ⁇ butyric acid
  • the beneficial effects of the present invention are as follows: the "endosome embryo" of the acceptor material used for Agrobacterium infection in the transformation of grapes of the present invention is induced by the zygotic embryo of the "nuclear-free ⁇ non-nuclear” grape hybrid, which is contained in the acceptor material.
  • the ratio of non-nuclear genes is high ( ⁇ 80%), so it is easier to obtain antiviral non-nuclear materials in transformed plants after transformation.
  • the main advantages of the RNAi antiviral vector used in the transformation of the grape of the present invention are: (1) the complete gene of the virus is not required, and only the partial fragment of the gene can also play a disease resistance; (2) The inserted gene fragment is small, which is conducive to vector construction and genetic transformation; (3) RNA invading the virus in the transgenic plant is rapidly degraded, and the virus gene is not required to express the protein, and the transgenic product is more safe and reliable; (4) single copy transformation It also produces highly resistant and even immune plants.
  • the invention combines the seedless grape embryo rescue technology with the transgenic technology, adopts the embryoid body of the seedless grape hybrid immature embryo obtained by embryo rescue as the acceptor material, and utilizes the conserved fragment containing the grape virus coat protein (CP) gene.
  • the RNAi antiviral vector is subjected to Agrobacterium-mediated genetic transformation, and a new grape material which is both antiviral and non-nuclear can be obtained from the transformed plant after transformation, and a new variety is selected.
  • Figure 1 is the PCR identification of the entry cloning vector pENTR-GV, wherein M: DL2000 marker; 1: pENTR-GV with M13-F & GV-R as primer PCR amplification results; 2: pENTR-GV with GV-F & GV-R as primer PCR amplification results;
  • Figure 2 is a Xho I digestion of the RNAi vector PH12-GV; wherein, M: DL2000 marker; 1: PH12-GV digestion results; 2: pHELLSGATE12 no-load digestion results;
  • Figure 3 is a Xba I digestion of the RNAi vector PH12-GV of the present invention, wherein M: DL2000 marker; 1: PH12-GV digestion results; 2: pHELLSGATE12 empty-cut digestion results;
  • Figure 4 is a PCR identification of EH-GV of the present invention. wherein, M: DL2000 marker; 1: EHA105 no-load PCR result; 2-3: PCR result of EH-GV engineering strain;
  • Figure 5 is a regenerated plant of the somatic embryo derived from the Agrobacterium EH-GV transformed zygotic embryo of the present invention, wherein D-1: somatic embryo after infection by Agrobacterium, D-2: post-embryonic germination of Agrobacterium transformant cells Resistant bud, D-3: Regenerated plant of post-embryo rooting of Agrobacterium tumefaciens cells, D-4: Transgenic plants transplanted into the greenhouse.
  • Example 1 Obtaining a grape zygotic embryo with a non-nuclear gene by hybridization and embryo rescue between seedless grape varieties:
  • Step A-1 artificial emasculation of the female cultivar 3 days before flowering (the female parent in this example is “red-faced non-nuclear”), and the inflorescences after emasculation are immediately sprayed with water and bagged and tagged. ;
  • Step A-2 On the 2-3rd day after emasculation, the father's pollen is taken with a writing brush (in this embodiment, the male parent is "flame without nuclear") scattered on the female stigma for artificial pollination;
  • Step A-3 6 weeks after pollination, collect young fruit in the field, rinse with tap water for 10 minutes; soak it in 70% alcohol for 1 minute on the ultra-clean workbench, then soak it in 0.1% HgCl 2 for 8 minutes, rinse with sterile water. 4 times;
  • Step A-4 the disinfected fruit pieces are placed in a sterile culture dish, and the ovules are taken out under aseptic conditions, and inoculated on the zygotic embryo development medium for ovule endogenous culture, and the zygote embryo development medium is solid-liquid double Phase TL medium, its composition and content are as follows: calcium nitrate 250.0mg / L, potassium nitrate 600.0mg / L, potassium chloride 75.0mg / L, ammonium nitrate 300.0mg / L, magnesium sulfate 1200.0mg / L, phosphoric acid Potassium dihydrogen 300.0mg / L, manganese sulfate 3.0mg / L, potassium iodide 0.8mg / L, Boric acid 0.5mg/L, zinc sulfate 0.5mg/L, sodium selenite 0.25mg/L, cobalt chloride 0.025mg/L, copper sulfate
  • Step A-5 after the ovule is cultured on the zygotic embryo development medium for 6 weeks, the developing immature embryos are taken out under aseptic conditions, and inoculated on the solid embryogenic callus induction medium, the embryogenic callus induction medium.
  • the composition is TL+0.5mg/L6-BA+1.0mg/L 2,4-D, with 30g/L of sucrose and 6.0g/L of agar; the gene with no nuclear gene (the ratio is above 80%) can be obtained. Grape zygotic embryo.
  • Step B-1 the hybrid zygotic embryo obtained in the step A is inoculated on the solid embryogenic callus induction medium, and the composition of the embryogenic callus induction medium is TL+0.5 mg/L 6-BA+1.0 mg. /L 2,4-D, wherein sucrose 30g / L, agar 6.0g / L;
  • Step B-2 After the zygotic embryo is cultured on the embryogenic callus induction medium for 4 weeks, the obtained yellow, granular, and compact embryogenic callus is inoculated on the solid somatic embryo differentiation medium.
  • the composition of the somatic embryo differentiation medium is TL+0.5 mg/L 6-BA+2.0 mg/L NAA, wherein 30 g/L of sucrose and 6.0 g/L of agar are added;
  • Step B-3 after the embryogenic callus is cultured on the somatic embryo differentiation medium for 4 weeks, a large number of somatic embryos can be induced.
  • most of the somatic embryo development stages are in the cotyledon stage. .
  • Step C-1 the construction process of the entry cloning vector
  • the RNAi interference fragment GV is 825 bp obtained by sequentially concatenating the conserved segments of the four grape virus coat protein genes of GFLV, GLRaV-3, GVA and GVB. Large fragment (see SEQ ID NO. 1 for the sequence).
  • PCR amplification was carried out using the GV upstream primer GV-F (the primer sequence is CACCATGGGTGATGAGCTTTGATGC, the sequence is shown in SEQ ID NO. 2) and the downstream primer GV-R (the primer sequence is TAGACTCTCAAGCTTGCTAA, the sequence is shown in SEQ ID NO. 3).
  • the PCR reaction system in this example is: 10 ⁇ Buffer 5 ⁇ L, dNTP mixtuer (2.5 mM of each dNTP) 5 ⁇ L, GV-F (10 ⁇ mol/L) 2 ⁇ L, GV-R (10 ⁇ mol/L) 2 ⁇ L, Pfu DNA Polymerase 1 ⁇ L, 1 ⁇ L of template, sterile double distilled water 34 ⁇ L, total volume 50 ⁇ L.
  • the PCR reaction parameters were: pre-denaturation at 94 ° C for 5 min; (degeneration at 94 ° C for 30 s, annealing at 56 ° C for 30 s, extension at 72 ° C for 40 s) for 35 cycles; 72 ° C for 10 min.
  • the PCR product was subjected to 1.0% agarose gel electrophoresis and the target strip was recovered to obtain a blunt-end PCR product containing the interference fragment (GV).
  • GV interference fragment
  • kit instructions were used to construct a 6 ⁇ L reaction system.
  • the reaction system used in this example was: Recovering the target gene fragment GV 1 ⁇ L, salt solution 1 ⁇ L, pENTR TM /SD/ Vector 1 ⁇ L, sterile ultrapure water 3 ⁇ L), reacted at 25°C for 30min, and the product was heat-induced to transform E. coli Top10 competent cells and evenly coated on LB solid medium plate containing 75mg/L kanamycin.
  • the PCR reaction system in this example is: 10 ⁇ Buffer 2 ⁇ L, dNTP mixtuer (2.5 mM of each dNTP) 1.6 ⁇ L, primer (10 ⁇ mol/L) 1 ⁇ L each 1 ⁇ L, rTaq DNA Polymerase 0.2 ⁇ L, template 1 ⁇ L, sterile double distilled water 13.2 ⁇ L, total volume 20 ⁇ L.
  • the PCR reaction parameters are the same as in step C-1.
  • Step C-2 RNAi vector construction process: The entry vector pENTR-GV and the target vector pHELLSGATE12 were subjected to LR reaction, and 20 ⁇ L reaction system was constructed according to the Gateway LR Clonase II Enzyme Mix kit instructions.
  • the reaction system of this example was: pENTR-GV 2 ⁇ L, pHELLSGATE 12, 2 ⁇ L, LR clonase enzyme mix 4 ⁇ L, Sterile water 12 ⁇ L. After 12 h of reaction at 25 ° C, the reaction was stopped by the addition of proteinase K. The reaction product was heat-transformed into E.
  • coli Top10 competent cells uniformly coated on LB medium plate containing 100 mg/L spectinomycin, inverted culture at 37 ° C for 16 h, and picked up to LB liquid medium containing the same concentration of Spec. After incubating for 14 h at 37 ° C, the plasmid was extracted and then digested with Xho I (Fig. 2) and Xba I (Fig. 3) (with pHELLSGATE12 empty control as control).
  • the Xba I digestion system was: Xba I 1 ⁇ L, 10x M Buffer 2 ⁇ L, 0.1% BSA2 ⁇ L, LR reaction product 6 ⁇ L, sterile ultrapure water 9 ⁇ L;
  • Xho I digestion system Xho I 1 ⁇ L, 10x H Buffer 2 ⁇ L, LR reaction product 6 ⁇ L, sterilized ultrapure water 11 ⁇ L .
  • the fragment size was about 900 bp, and the size of the fragment was significantly different from that of unreacted PHELLSGATE12 (Xho I was 1429 bp).
  • the Xba I excised fragment was 1419 bp), and it was confirmed that the recombinant plasmid was a constructed RNAi vector, which was named PH12-GV in this example.
  • Step C-3 RNAi vector transformation of Agrobacterium tumefaciens
  • transforming PH12-GV vector into Agrobacterium strain EHA105 competent cells uniformly coated on YEB plate containing 50 mg/L rifampicin and 100 mg/L spectinomycin
  • On the base incubate at 48 °C for 48 h, pick the monoclonal to the same concentration of rifampicin and spectinomycin in YEB liquid medium for 28 h at 28 °C, and use GV-F&GV-R as primer to carry out bacterial PCR amplification.
  • Increase, 1.0% agarose gel electrophoresis, PCR reaction system and reaction parameters are the same as step C-1.
  • Example 4 Agrobacterium transforms zygotic embryo-derived somatic embryos to obtain regenerated plants
  • Step D-1 28 ° C, 200 rpm
  • the RNAi plant expression vector engineering strain EH-GV transformed with Agrobacterium was shake cultured in YEB liquid medium containing 50 mg/L rifampicin for 48 hours until the OD value was about
  • the precipitated cells were collected, resuspended in an equal volume of WPM liquid medium, and the somatic embryos obtained in the step B-3 were inoculated with Agrobacterium liquid for 10-15 minutes.
  • Step D-2 the infected somatic embryos are placed in a sterile culture dish, and the excess bacterial solution is blotted with the sterilized filter paper, inoculated on a WPM solid medium, and cultured for 3 days in the dark.
  • Step D-3 after inoculation of the infected somatic embryos in WPM + 0.2 mg / L 6 - BA + 50 mg / L kanamycin (Kan) + 200 mg / L cephalosporin (Cef) + 200 mg / L carboxy
  • Kan kanamycin
  • Cef cephalosporin
  • the cells were cultured on benzylpenicillin (Carb) medium for 3 months under the conditions of 16 h/8 h photoperiod, and subcultured every 2 weeks.
  • Step D-4 culturing the resistant bud obtained by germination in 1/2MS+0.2mg/L indolebutyric acid (IBA)+25mg/L kanamycin (Kan)+200mg/L Cef+200mg/L Carb culture
  • IBA indolebutyric acid
  • Kan kanamycin
  • the test tube seedlings after rooting were 1/2MS+0.2mg/L IBA+25mg/L Kan+200mg/L Cef+200mg/LCarb
  • the regenerated plants with strong growth and good rooting are selected for refining and transplanting in the greenhouse.
  • the plants with good root development under in vitro conditions are washed with water after being reheated in the greenhouse.
  • the attached agar is transplanted into a nutrient bowl containing nutrient soil, and the lived seedlings are routinely managed to develop into a robust grape plant.
  • Step E-2 After surface disinfection of the leaves with 70% alcohol, dry them thoroughly. After rubbing the upper surface of the leaves with quartz sand to make a slight wound, use the fingers to pick up the virus extract and inoculate the seeds into the young leaves of the grapes. The plants were inoculated with 5 leaves, and the untransformed plants were inoculated as a control. After 20 days, the plants were tested with DAS-ELISA.
  • Step E-3 take 100 mg of the top leaves of the test plants, grind in 1 ml of PBS buffer, centrifuge, and take the supernatant, and dilute the antibody to 1 g with 0.1 mol/L (pH 9.6) carbonate coating buffer.
  • Table 1 show that the control plants showed a susceptibility response to the four viruses after virus inoculation, and the transgenic plants obtained after transformation showed the disease resistance reaction in most cases.
  • the strains TrGV-1, TrGV-3, and TrGV-4 showed the most serious four viruses (GFLV, GLRaV-3, GVA, GVB) in grape production.
  • the reaction; the strain TrGV-2 showed only a disease for the virus GVB, but showed resistance to the other three viruses. It indicated that the virus accumulation of these transgenic plants was significantly reduced after inoculation of the virus, and thus the disease resistance was significantly improved.

Abstract

Disclosed is a biotechnological breeding method for obtaining antiviral seedless grapes. The method comprises the following steps: obtaining zygotic embryos containing seedless genes by carrying out hybridization between varieties of seedless grapes and embryo rescue, and inducing grape somatic embryogenesis by means of the zygotic embryos; and carrying out agrobacterium tumefaciens-mediated genetic transformation by using RNAi antiviral vectors containing conservative gene segments of grape virus coat protein (CP), so that a grape material which is both antiviral and seedless can be obtained from transformed regeneration plants.

Description

一种获得抗病毒无核葡萄的生物技术育种方法Biotechnology breeding method for obtaining antiviral seedless grape 技术领域Technical field
本发明属于农业生物技术育种技术领域,具体涉及一种获得抗病毒无核葡萄的生物技术育种方法。The invention belongs to the technical field of agricultural biotechnology breeding, and particularly relates to a biotechnology breeding method for obtaining antiviral seedless grapes.
背景技术Background technique
葡萄是世界上最古老的果树树种之一,以其味美多汁、营养丰富及具有多种保健功能深受国内外消费者喜爱,近年来,国内外市场对鲜食葡萄品种的要求也越来越高,尤其是无核葡萄越来越受到人们的青睐,现有无核葡萄品种已不能满足生产上的需求。同时,葡萄也是感染病毒种类最多的果树树种[Martelli等.Grapevine virology highlights:2010-2012.Proceedings of the 17th Congress of ICVG,Davis,Califomia,USA,2012:13-31]。近年来,我国各地竞相发展葡萄,地区间引种比较频繁,病毒本身可随苗木进行远距离传播,导致一些地方病害蔓延。据调查[刘晓等.部分葡萄品种的病毒病鉴定及健康状况评价.果树学报,2006,23(6):846-849],我国多数主栽品种和砧木普遍带毒,有些品种的带毒株率几乎达到100%。其中,葡萄扇叶病毒(GFLV)、葡萄卷叶病毒(GLRaV,主要病原是GLRaV-3)葡萄病毒A(GVA)和葡萄病毒B(GVB)是生产中最为广泛存在的4种危险性病毒,目前,葡萄病毒病已成为我国果树生产中亟待解决的问题,现有技术水平下全世界尚无有效的药剂防治办法,而培育抗病品种无疑是一条最为经济有效的途径。Grape is one of the oldest fruit tree species in the world. It is popular among domestic and foreign consumers for its succulent, nutritious and multi-health functions. In recent years, the demand for table grape varieties in the domestic and foreign markets has also come. The higher, especially the non-nuclear grapes are more and more popular, and the existing seedless grape varieties can no longer meet the production needs. At the same time, grapes are also the most fruit species of the virus species [Martelli et al. Grapevine virology highlights: 2010-2012. Proceedings of the 17th Congress of ICVG, Davis, Califomia, USA, 2012: 13-31]. In recent years, grapes have been developed in various parts of China, and introductions have been frequent between regions. The virus itself can spread long distances with seedlings, leading to the spread of diseases in some places. According to the survey [Liu Xiao et al. Viral disease identification and health status evaluation of some grape varieties. Journal of Fruit Science, 2006, 23 (6): 846-849], most of the main varieties and rootstocks in China are generally poisonous, and some varieties are poisonous. The strain rate is almost 100%. Among them, grape leaf fan virus (GFLV), grape leaf curl virus (GLRaV, the main pathogen is GLRaV-3) grape virus A (GVA) and grape virus B (GVB) are the four most dangerous viruses in production. At present, grape virus disease has become an urgent problem in the production of fruit trees in China. There is no effective drug control method in the world under the current technical level, and breeding resistant varieties is undoubtedly the most economical and effective way.
现代葡萄育种的理论[Ramming等.Hybridization of seedless grapes.Vitis,1990(Special issue):439-444]认为,采用“无核×无核”葡萄品种间杂交,通过胚挽救的方法容易获得无核后代,杂种后代中无核类型比例可达80%以上。目前,这种生物技术育种方法已成功应用于无核葡萄育种技术领域[田莉莉等.Seedless grape breeding for disease resistance by using embryo rescue.Vitis,2008,47(1):15-19;田莉莉等.Breeding of disease-resistant seedless grapes using Chinese wild Vitis spp.I.In vitro embryo rescue and plant development.Scientia Horticulturae,2008,117(2):136-141]。同时,在植物抗病毒育种方面,利用植物外壳蛋白基因转化植物是目前培育抗病品种的主要手段。近年来,RNAi技术的发展为植物转基因抗病毒提供了新策略。前人的研究表明,转化病毒外壳蛋白基因的全部或部分片段构建的RNAi载体,均能获得抗病的转基因植株[朱常香等.多抗 PVY、TMV和CMV转基因烟草的培育.中国农业科学,2008,41(4):1040-1047]。多数研究者在构建RNAi载体时,通常选取的是病毒基因组中相对保守的片段作为干扰片段,这样还可以减少因病毒变异造成的转基因植株抗病性的丧失[Xu等.Conserved sequences of replicas gene-mediated resistance to Potyvirus through RNA silencing.Journal of Plant Biology,2009,52(6):550-559]。The theory of modern grape breeding [Ramming et al. Hybridization of seedless grapes. Vitis, 1990 (Special issue): 439-444] believes that the use of "nuclear-free × non-nuclear" grape varieties hybridization, easy to obtain non-nuclear by embryo rescue method In the offspring, the proportion of non-nuclear types in hybrid offspring can reach more than 80%. At present, this biotechnology breeding method has been successfully applied to the field of seedless grape breeding technology [Teachless grape breeding for disease resistance by using embryo rescue.Vitis, 2008, 47(1): 15-19; Tian Lili et al. .Breeding of disease-resistant seedless grapes using Chinese wild Vitis spp. I. In vitro embryo rescue and plant development. Scientia Horticulturae, 2008, 117(2): 136-141]. At the same time, in plant antiviral breeding, the use of plant coat protein gene to transform plants is currently the main means of breeding resistant varieties. In recent years, the development of RNAi technology has provided a new strategy for plant transgenic antiviral. Previous studies have shown that RNAi vectors constructed by transforming all or part of the viral coat protein gene can obtain disease-resistant transgenic plants [Zhu Changxiang et al. Cultivation of PVY, TMV and CMV Transgenic Tobacco. China Agricultural Sciences, 2008, 41(4): 1040-1047]. Most researchers in the construction of RNAi vectors usually select relatively conserved fragments in the viral genome as interference fragments, which can also reduce the loss of disease resistance of transgenic plants caused by viral mutations [Xu et al. Conserved sequences of replicas gene- Mediated resistance to Potyvirus through RNA silencing. Journal of Plant Biology, 2009, 52(6): 550-559].
目前普遍采用的胚挽救技术培育无核葡萄方法尚存在不足之处:由于生产上栽培的多数无核葡萄属于欧亚种,虽然品质优良但抗病性普遍较差,通过胚挽救这一技术虽然容易获得“无核×无核”的无核后代,但获得的无核葡萄往往比亲本更不抗病,更容易受到自然界中各种病毒的危害,因此,仅仅依靠胚挽救这一单一的生物技术手段获得的无核葡萄,在抗病毒病方面存在很大缺陷。At present, the commonly used method of embryo rescue technology to cultivate seedless grape has some inadequacies: most of the non-nuclear grapes cultivated in production belong to the Eurasian species, although the quality is good but the disease resistance is generally poor. It is easy to obtain “nuclear-free × non-nuclear” non-nuclear offspring, but the obtained non-nuclear grapes are often less resistant to disease than the parents, and are more vulnerable to various viruses in nature. Therefore, relying solely on embryos to save this single organism The non-nuclear grapes obtained by technical means have great defects in antiviral diseases.
采用传统的葡萄转基因技术培育抗病毒葡萄的缺点:(1)必需利用完整基因翻译策略,转基因产品无法排除安全隐患;(2)转化植株的抗病毒反应多数表现为延迟发病,属于耐病性;(3)如果外源基因片段过大,容易出现目的基因仅部分导入或导入基因仅能部分表达的现象;(4)转化植株高抗病性的获得往往需要多拷贝。The disadvantages of using traditional grape transgenic technology to cultivate antiviral grapes are as follows: (1) It is necessary to use the complete gene translation strategy, and the genetically modified products cannot eliminate safety hazards; (2) the antiviral response of transformed plants is mostly delayed, which is disease-resistant; 3) If the exogenous gene fragment is too large, it is prone to the phenomenon that only the partial introduction or introduction of the gene of interest can only be partially expressed; (4) The high disease resistance of the transformed plant often requires multiple copies.
目前,虽然通过胚挽救的方法可以培育无核葡萄新品种,但由于多数无核葡萄属于欧亚种,普遍存在抗病性差的缺点,而靠胚挽救这一单一的生物技术手段技术获得的无核葡萄后代往往比它们的亲本更不抗病,更容易受到各种病毒的威胁。At present, although the new seedless grape varieties can be cultivated by the method of embryo rescue, since most of the seedless grapes belong to the Eurasian species, the shortcomings of poor disease resistance are common, and the single biotechnology means of embryo rescue is obtained. Nuclear grape offspring are often less resistant to disease than their parents and are more susceptible to various viruses.
发明内容Summary of the invention
本发明的目的是提供一种获得抗病毒无核葡萄的生物技术育种方法,在无核葡萄育种技术领域,将胚挽救技术和转基因两种生物技术手段进行有机融合,在对无核葡萄杂种胚进行离体培养的过程中,利用带有无核基因的合子胚诱导发生的胚状体作为转基因受体材料,设法导入含有病毒外壳蛋白基因的RNAi抗病毒载体,从而获得既抗病毒病又无核的葡萄再生植株新材料。The object of the present invention is to provide a biotechnology breeding method for obtaining antiviral seedless grape. In the field of seedless grape breeding technology, the embryo rescue technology and the transgenic two biotechnology methods are organically fused in the non-nuclear grape hybrid embryo. In the process of in vitro culture, the embryoid body induced by the zygotic embryo with the non-nuclear gene is used as a transgenic receptor material, and an RNAi antiviral vector containing the viral coat protein gene is introduced to obtain an antiviral disease. Nuclear grape regeneration plant new material.
本发明所采用的技术方案是,一种获得抗病毒无核葡萄的生物技术育种方法,包括以下步骤:The technical solution adopted by the invention is a biotechnology breeding method for obtaining antiviral seedless grapes, comprising the following steps:
步骤1、通过无核葡萄品种间杂交和胚挽救获得带无核基因的葡萄合子胚; Step 1. Obtaining a grape zygotic embryo with a non-nuclear gene by crossing between the seedless grape varieties and embryo rescue;
步骤2、通过合子胚诱导发生葡萄体细胞胚; Step 2. Inducing the growth of grape somatic embryos by zygotic embryos;
步骤3、构建RNAi抗病毒植物表达载体并转入根癌农杆菌; Step 3. Construct an RNAi antiviral plant expression vector and transfer it to Agrobacterium tumefaciens;
步骤4、农杆菌转化合子胚来源的体细胞胚获得再生植株。 Step 4. Agrobacterium transforms the somatic embryo derived from the zygotic embryo to obtain a regenerated plant.
本发明的特点还在于: The invention also features:
步骤1中通过无核葡萄品种间杂交和胚挽救获得带无核基因的葡萄合子胚具体为:In step 1, the grape zygotic embryo with the non-nuclear gene obtained by hybridization and embryo rescue of the seedless grape variety is specifically:
步骤1.1、开花前3天对母本品种进行人工去雄,去雄后的花序立即用清水喷洗干净并套袋、挂牌标记;Step 1.1: Artificial emasculation of the female parent species 3 days before flowering, the inflorescences after emasculation are immediately sprayed clean with water and bagged and tagged;
步骤1.2、去雄后第2-3天用毛笔蘸取父本花粉散落在母本柱头上进行人工授粉;Step 1.2: On the 2-3rd day after the emasculation, the father's pollen is collected by the brush and scattered on the stigma of the female parent for artificial pollination;
步骤1.3、授粉后6周田间采集幼果,自来水冲洗10min;在超净工作台上用70%的酒精浸泡1分钟后,再用0.1%的HgCl2浸泡消毒8分钟,无菌水漂洗4次;Step 1.3: After 6 weeks of pollination, the young fruit was collected in the field, rinsed with tap water for 10 min; soaked in 70% alcohol for 1 minute on the ultra-clean workbench, then immersed in 0.1% HgCl 2 for 8 minutes, rinsed 4 times with sterile water. ;
步骤1.4、消毒后的果粒置于灭过菌的培养皿中,无菌条件下取出胚珠,接种在合子胚发育培养基上进行胚珠内胚培养,合子胚发育培养基为固液双相的TL培养基;Step 1.4: The sterilized fruit pieces are placed in a sterilized culture dish, and the ovules are taken out under aseptic conditions, and inoculated on the zygotic embryo development medium for ovule endogenous culture, and the zygotic embryo development medium is solid-liquid two-phase. TL medium;
步骤1.5、胚珠在合子胚发育培养基上培养6周后,无菌条件下取出发育的幼胚,接种在固体的胚性愈伤组织诱导培养基上;即获得带无核基因的葡萄合子胚。Step 1.5: After the ovule is cultured on the zygotic embryo development medium for 6 weeks, the developing immature embryos are taken out under aseptic conditions, and inoculated on the solid embryogenic callus induction medium; that is, the grape zygotic embryo with the non-nuclear gene is obtained. .
TL培养基的组分和含量如下:硝酸钙250.0mg/L,硝酸钾600.0mg/L,氯化钾75.0mg/L,硝酸铵300.0mg/L,硫酸镁1200.0mg/L,磷酸二氢钾300.0mg/L,硫酸锰3.0mg/L,碘化钾0.8mg/L,硼酸0.5mg/L,硫酸锌0.5mg/L,亚硒酸钠0.25mg/L,氯化钴0.025mg/L,硫酸铜0.025mg/L,钼酸钠0.025mg/L,柠檬酸铁10.0mg/L,盐酸硫胺素0.25mg/L,盐酸吡哆辛0.25mg/L,D-泛酸钙0.25mg/L,烟酸0.25mg/L,天冬酰胺300mg/L,甘氨酸5.0mg/L,精氨酸2.0mg/L,肌醇50.0mg/L,水解酪蛋白500.0mg/L,L-半胱氨酸121.16mg/L,蔗糖30000mg/L,琼脂6000mg/L,其余为蒸馏水,其中附加蔗糖6.0g/L,活性炭1.5g/L;步骤1.5中诱导培养基为:胚性愈伤组织诱导培养基的成分为TL+0.5mg/L6-BA+1.0mg/L 2,4-D,其中附加蔗糖30g/L,琼脂6.0g/L。The composition and content of TL medium are as follows: calcium nitrate 250.0 mg / L, potassium nitrate 600.0 mg / L, potassium chloride 75.0 mg / L, ammonium nitrate 300.0 mg / L, magnesium sulfate 1200.0 mg / L, potassium dihydrogen phosphate 300.0mg/L, manganese sulfate 3.0mg/L, potassium iodide 0.8mg/L, boric acid 0.5mg/L, zinc sulfate 0.5mg/L, sodium selenite 0.25mg/L, cobalt chloride 0.025mg/L, copper sulfate 0.025mg/L, sodium molybdate 0.025mg/L, ferric citrate 10.0mg/L, thiamine hydrochloride 0.25mg/L, pyridoxine hydrochloride 0.25mg/L, D-pantothenate 0.25mg/L, nicotinic acid 0.25mg/L, asparagine 300mg/L, glycine 5.0mg/L, arginine 2.0mg/L, inositol 50.0mg/L, hydrolyzed casein 500.0mg/L, L-cysteine 121.16mg/ L, sucrose 30000mg / L, agar 6000mg / L, the rest is distilled water, which added 6.0g / L sucrose, activated carbon 1.5g / L; step 1.5 in the induction medium: embryogenic callus induction medium composition of TL +0.5 mg/L 6-BA + 1.0 mg/L 2,4-D, with 30 g/L of sucrose and 6.0 g/L of agar.
步骤2中通过合子胚诱导发生体细胞胚具体为:In step 2, the somatic embryos induced by zygotic embryos are specifically:
步骤2.1、将步骤1获得的杂交合子胚接种在固体的胚性愈伤组织诱导培养基上;Step 2.1, inoculation of the hybrid zygotic embryo obtained in step 1 on a solid embryogenic callus induction medium;
步骤2.2、合子胚在胚性愈伤组织诱导培养基上培养4周后,将获得的黄色、颗粒状、发育紧实的胚性愈伤组织接种在固体的体细胞胚分化培养基上;Step 2.2: After the zygotic embryo is cultured on the embryogenic callus induction medium for 4 weeks, the obtained yellow, granular, and compact embryogenic callus is inoculated on the solid somatic embryo differentiation medium;
步骤2.3、胚性愈伤组织在体细胞胚分化培养基上培养4周后,即可诱导获得大量的体细胞胚,此时多数体细胞胚发育时期处在子叶型期。Step 2.3: After the embryogenic callus is cultured on the somatic embryo differentiation medium for 4 weeks, a large number of somatic embryos can be induced, and at this time, most somatic embryo development stages are in the cotyledon stage.
步骤2.1中胚性愈伤组织诱导培养基的成分为TL+0.5mg/L6-BA+1.0mg/L 2,4-D,其中附加蔗糖30g/L,琼脂6.0g/L;所述步骤2.3中体细胞胚分化培养基的成分为TL+0.5mg/L 6-BA+2.0mg/L NAA,其中,附加蔗糖30g/L,琼脂6.0g/L。The composition of the embryogenic callus induction medium in step 2.1 is TL+0.5mg/L6-BA+1.0mg/L 2,4-D, wherein sucrose 30g/L and agar 6.0g/L are added; step 2.3 The composition of the medium somatic embryo differentiation medium was TL+0.5 mg/L 6-BA+2.0 mg/L NAA, wherein 30 g/L of sucrose and 6.0 g/L of agar were added.
步骤3中构建RNAi抗病毒植物表达载体并转入根癌农杆菌具体为:The RNAi antiviral plant expression vector is constructed in step 3 and transferred to Agrobacterium tumefaciens:
步骤3.1、构建入门克隆载体:RNAi干扰片段GV是GFLV、GLRaV-3、GVA和GVB 4个葡萄病毒外壳蛋白基因的保守区段顺序串联后获得的825bp的大片段,序列见SEQ ID NO.1;用添加接头CACC的GV上游引物GV-F和下游引物GV-R进行PCR扩增,PCR产物经1.0%的琼脂糖凝胶电泳后目标条带切胶回收,获得含干扰片段GV的平末端PCR产物;构建6μL连接反应体系,25℃条件下反应30min,连接产物热激法转化大肠杆菌Top10感受态细胞,均匀涂布在含75mg/L卡那霉素的LB固体培养基平板上,37℃倒置培养16h,挑单克隆到含有相同浓度Kan的LB液体培养基中37℃震荡培养14h,扩增片段的长度明显大于插入片段GV的长度,即构建好入门克隆载体;命名为pENTR-GV;Step 3.1, Construction of the entry cloning vector: RNAi interference fragment GV is GFLV, GLRaV-3, GVA and GVB The 825 bp large fragment obtained by sequential concatenation of the four grape virus coat protein genes was sequenced in SEQ ID NO. 1; PCR amplification was carried out with GV upstream primer GV-F and downstream primer GV-R added with linker CACC. The PCR product was subjected to 1.0% agarose gel electrophoresis and the target band was cut and recovered to obtain the blunt-end PCR product containing the interference fragment GV; 6 μL of the ligation reaction system was constructed, and the reaction was carried out at 25 ° C for 30 min, and the product was transformed by heat shock method. E. coli Top10 competent cells were uniformly coated on LB solid medium plates containing 75 mg/L kanamycin, inverted culture at 37 ° C for 16 h, and monoclonal clones were shaken at 37 ° C in LB liquid medium containing the same concentration of Kan. After 14 hours of culture, the length of the amplified fragment was significantly larger than the length of the insert GV, that is, the entry cloning vector was constructed; named pENTR-GV;
步骤3.2、构建RNAi载体:将入门载体pENTR-GV和目标载体pHELLSGATE12进行LR反应,构建20μL LR反应体系;25℃条件下反应12h后,加入蛋白酶K终止反应;反应产物热激法转化大肠杆菌Top10感受态细胞,均匀涂布在含有100mg/L壮观霉素(Spec)的LB培养基平板上,37℃倒置培养16h,挑单克隆到含相同浓度Spec的LB液体培养基中37℃震荡培养14h,提取质粒后用Xho I和Xba I进行单酶切,以pHELLSGATE12空载作对照;LR反应之后的重组质粒经Xho I和Xba I进行单酶切后切下片段大小分别为917bp和915bp,且明显区别于未经反应的PHELLSGATE12空载切出的片段大小(空载用Xho I切出片段为1429bp,Xba I切出片段为1419bp),则重组质粒为构建好的RNAi载体,命名为PH12-GV;Step 3.2: Construction of RNAi vector: LR reaction of the entry vector pENTR-GV and the target vector pHELLSGATE12 to construct a 20 μL LR reaction system; after reacting at 25 ° C for 12 h, the reaction was terminated by adding proteinase K; the reaction product was heat-transformed into E. coli Top10 Competent cells were uniformly coated on LB medium plates containing 100 mg/L spectinomycin (Spec), inverted culture at 37 ° C for 16 h, and monoclonal cloned into LB liquid medium containing the same concentration of Spec in shaking culture at 37 ° C for 14 h. After extracting the plasmid, the plasmid was digested with Xho I and Xba I, and the pHELLSGATE12 was used as a control. The recombinant plasmid after LR reaction was digested with Xho I and Xba I, and the fragment size was 917 bp and 915 bp, respectively. Significantly different from the fragment size of unreacted PHELLSGATE12 empty-cut (1429 bp for Xho I and 1419 bp for Xba I), the recombinant plasmid was constructed as RNAi vector and named PH12- GV;
步骤3.3、RNAi载体转化根癌农杆菌:将PH12-GV载体转化农杆菌菌株EHA105感受态细胞,均匀涂布在含有50mg/L利福平和100mg/L壮观霉素的YEB平板培养基上,28℃条件下倒置培养48h,挑单克隆到含有相同浓度的利福平和壮观霉素的YEB液体培养基中28℃震荡培养48h,用GV-F和GV-R作引物进行菌液PCR扩增,1.0%琼脂糖凝胶电泳,PCR产物为829bp的片段,则RNAi植物表达载体工程菌株已转化好,命名为EH-GV。Step 3.3: RNAi vector transformation Agrobacterium tumefaciens: The PH12-GV vector was transformed into Agrobacterium strain EHA105 competent cells, and uniformly coated on YEB plate medium containing 50 mg/L rifampicin and 100 mg/L spectinomycin, 28 Incubate for 48 h under °C conditions, pick the monoclonal to the same concentration of rifampicin and spectinomycin in YEB liquid medium for 28 h at 28 °C, and use GV-F and GV-R as primers for PCR amplification. After electrophoresis on a 1.0% agarose gel, the PCR product was a 829 bp fragment, and the RNAi plant expression vector engineering strain was transformed and named EH-GV.
GV的上游引物GV-F的序列如SEQ ID NO.2所示,具体为:CACCATGGGTGATGAGCTTTGATGC;所述GV的下游引物的序列如SEQ ID NO.3所示,具体为:TAGACTCTCAAGCTTGCTAA;The sequence of the GV-F upstream primer GV-F is shown in SEQ ID NO. 2, specifically: CACCATGGGTGATGAGCTTTGATGC; the sequence of the downstream primer of the GV is shown in SEQ ID NO. 3, specifically: TAGACTCTCAAGCTTGCTAA;
步骤3.1和步骤3.3中的PCR反应体系为:10×Buffer 5μL,dNTP mixtuer 5μL,10μmol/L的GV-F 2μL,10μmol/L的GV-R 2μL,Pfu DNA Polymerase 1μL,模板1μL,灭菌双蒸水34μL,总体积50μL;PCR反应参数为:94℃预变性5min;94℃变性30s,56℃退火30s,72℃延伸40s,共35个循环;72℃延伸10min;The PCR reaction system in step 3.1 and step 3.3 is: 10×Buffer 5 μL, dNTP mixtuer 5 μL, 10 μmol/L GV-F 2 μL, 10 μmol/L GV-R 2 μL, Pfu DNA Polymerase 1 μL, template 1 μL, sterilization double 34μL of distilled water, the total volume of 50μL; PCR reaction parameters: pre-denaturation at 94 °C for 5min; denaturation at 94 °C for 30s, annealing at 56 °C for 30s, extension at 72 °C for 40s, a total of 35 cycles; 72 °C extension for 10min;
M13-F的序列如SEQ ID NO.4所示,具体为:GTAAAACGACGGCCAGT。 The sequence of M13-F is shown in SEQ ID NO. 4, specifically: GTAAAACGACGGCCAGT.
步骤3.1中所用连接反应体系为:回收目的基因片段GV 1μL,salt solution 1μL,pENTRTM/SD/
Figure PCTCN2015000519-appb-000001
vector 1μL,灭菌超纯水3μL。
The ligation reaction system used in step 3.1 is: recovery of the target gene fragment GV 1 μL, salt solution 1 μL, pENTR TM /SD/
Figure PCTCN2015000519-appb-000001
Vector 1 μL, 3 μL of sterile ultrapure water.
步骤3.2中的Xba I酶切体系为:Xba I 1μL,10x M Buffer 2μL,0.1%BSA 2μL,LR反应产物6μL,灭菌超纯水9μL;Xho I酶切体系为:Xho I 1μL,10x H Buffer2μL,LR反应产物6μL,灭菌超纯水11μL。The Xba I digestion system in step 3.2 is: Xba I 1 μL, 10×M Buffer 2 μL, 0.1% BSA 2 μL, LR reaction product 6 μL, sterile ultrapure water 9 μL; Xho I digestion system: Xho I 1 μL, 10× H Buffer 2 μL, LR reaction product 6 μL, and sterile ultrapure water 11 μL.
步骤3.2中的LR反应体系为:pENTR-GV 2μL,pHELLSGATE12,2μL,LR clonase enzyme mix 4μL;Sterile water 12μL。The LR reaction system in the step 3.2 was: pENTR-GV 2 μL, pHELLSGATE 12, 2 μL, LR clonase enzyme mix 4 μL; Sterile water 12 μL.
步骤4中农杆菌转化合子胚来源的体细胞胚获得再生植株具体为:In step 4, the Agrobacterium-derived zygotic embryo-derived somatic embryos obtain regenerated plants as follows:
步骤4.1、28℃、200rpm条件下,将转化农杆菌后的RNAi植物表达载体工程菌株EH-GV在含有50mg/L利福平的YEB液体培养基中震荡培养48小时,至OD值约为0.5,5000rpm离心10分钟后收集沉淀的菌体,用等体积的WPM液体培养基重悬,将步骤2.3获得的体细胞胚用农杆菌菌液浸泡侵染10-15分钟;Step 4.1, at 28 ° C, 200 rpm, the RNAi plant expression vector engineering strain EH-GV transformed with Agrobacterium was shake cultured in YEB liquid medium containing 50 mg/L rifampicin for 48 hours until the OD value was about 0.5. After centrifugation at 5000 rpm for 10 minutes, the precipitated cells were collected, resuspended in an equal volume of WPM liquid medium, and the somatic embryo obtained in step 2.3 was inoculated with Agrobacterium liquid for 10-15 minutes;
步骤4.2、侵染后的体细胞胚置于灭过菌的培养皿中,用灭过菌的滤纸吸干多余菌液,接种在WPM固体培养基上,黑暗条件下培养3天;Step 4.2: The infected somatic embryo is placed in a sterile culture dish, and the excess bacterial solution is blotted with the sterile filter paper, inoculated on the WPM solid medium, and cultured for 3 days in the dark;
步骤4.3、之后将侵染后的体细胞胚接种在WPM+0.2mg/L6-BA+50mg/L卡那霉素(Kan)+200mg/L头孢霉素(Cef)+200mg/L羧苄青霉素(Carb)培养基上,在16h/8h光周期条件下培养3个月,每2周继代一次;Step 4.3, after inoculation of the infected somatic embryos in WPM + 0.2 mg / L 6 - BA + 50 mg / L kanamycin (Kan) + 200 mg / L cephalosporin (Cef) + 200 mg / L carbenicillin (Carb) medium, cultured for 3 months under the conditions of 16h/8h photoperiod, once every 2 weeks;
步骤4.4、将萌发获得的抗性芽培养在1/2MS+0.2mg/L吲哚丁酸(IBA)+25mg/L Kan+200mg/L Cef+200mg/LCarb培养基上,在16h/8h光周期条件下培养2个月,每4周继代一次,生根后的试管苗在1/2MS+0.2mg/L IBA+25mg/L Kan+200mg/L Cef+200mg/LCarb培养基上扩大培养后,选择生长健壮、生根良好的再生植株在温室内进行炼苗和移栽,制备得到抗病毒无核葡萄。Step 4.4, cultivating the resistant bud obtained by germination on 1/2MS+0.2mg/L 吲哚butyric acid (IBA)+25mg/L Kan+200mg/L Cef+200mg/L Carb medium at 16h/8h light Incubate for 2 months under cyclic conditions, subculture every 4 weeks, and the tube seedlings after rooting are expanded on 1/2MS+0.2mg/L IBA+25mg/L Kan+200mg/L Cef+200mg/L Carb medium. Regenerated plants with strong growth and good rooting are cultivated and transplanted in the greenhouse to prepare antiviral seedless grapes.
本发明的有益效果是:本发明转化葡萄时农杆菌侵染所采用的受体材料“体细胞胚”为“无核×无核”葡萄杂交后的合子胚诱导所得,由于受体材料中含有无核基因的比率很高(≥80%),所以在转化后的再生植株中比较容易获得抗病毒的无核材料。The beneficial effects of the present invention are as follows: the "endosome embryo" of the acceptor material used for Agrobacterium infection in the transformation of grapes of the present invention is induced by the zygotic embryo of the "nuclear-free × non-nuclear" grape hybrid, which is contained in the acceptor material. The ratio of non-nuclear genes is high (≥80%), so it is easier to obtain antiviral non-nuclear materials in transformed plants after transformation.
与传统的转基因方法相比,本发明转化葡萄所采用RNAi抗病毒载体的主要优点在于:(1)不需要病毒的完整基因,只需基因部分片段也可起到抗病作用;(2)转入的基因片段较小,有利于载体构建和遗传转化;(3)在转基因植株中侵入病毒的RNA迅速被降解,不需要病毒基因表达蛋白质,转基因产品更加安全可靠;(4)单拷贝的转化子也能产生高度抗病甚至免疫的植株。 Compared with the traditional transgenic method, the main advantages of the RNAi antiviral vector used in the transformation of the grape of the present invention are: (1) the complete gene of the virus is not required, and only the partial fragment of the gene can also play a disease resistance; (2) The inserted gene fragment is small, which is conducive to vector construction and genetic transformation; (3) RNA invading the virus in the transgenic plant is rapidly degraded, and the virus gene is not required to express the protein, and the transgenic product is more safe and reliable; (4) single copy transformation It also produces highly resistant and even immune plants.
本发明通过将无核葡萄胚挽救技术与转基因技术相结合,采用胚挽救获得的无核葡萄杂交幼胚起源的胚状体作为受体材料,同时利用含有葡萄病毒外壳蛋白(CP)基因保守片段的RNAi抗病毒载体进行农杆菌介导的遗传转化,可以从转化后的再生植株中获得既抗病毒病又无核的葡萄新材料,进而选育新品种。The invention combines the seedless grape embryo rescue technology with the transgenic technology, adopts the embryoid body of the seedless grape hybrid immature embryo obtained by embryo rescue as the acceptor material, and utilizes the conserved fragment containing the grape virus coat protein (CP) gene. The RNAi antiviral vector is subjected to Agrobacterium-mediated genetic transformation, and a new grape material which is both antiviral and non-nuclear can be obtained from the transformed plant after transformation, and a new variety is selected.
附图说明DRAWINGS
图1是入门克隆载体pENTR-GV的PCR鉴定,其中,M:DL2000marker;1:pENTR-GV以M13-F&GV-R作引物PCR扩增结果;2:pENTR-GV以GV-F&GV-R作引物PCR扩增结果;Figure 1 is the PCR identification of the entry cloning vector pENTR-GV, wherein M: DL2000 marker; 1: pENTR-GV with M13-F & GV-R as primer PCR amplification results; 2: pENTR-GV with GV-F & GV-R as primer PCR amplification results;
图2是RNAi载体PH12-GV的Xho I酶切鉴定;其中,M:DL2000marker;1:PH12-GV酶切结果;2:pHELLSGATE12空载酶切结果;Figure 2 is a Xho I digestion of the RNAi vector PH12-GV; wherein, M: DL2000 marker; 1: PH12-GV digestion results; 2: pHELLSGATE12 no-load digestion results;
图3是本发明RNAi载体PH12-GV的Xba I酶切鉴定,其中,M:DL2000marker;1:PH12-GV酶切结果;2:pHELLSGATE12空载酶切结果;Figure 3 is a Xba I digestion of the RNAi vector PH12-GV of the present invention, wherein M: DL2000 marker; 1: PH12-GV digestion results; 2: pHELLSGATE12 empty-cut digestion results;
图4是本发明EH-GV的PCR鉴定;其中,M:DL2000marker;1:EHA105空载PCR结果;2-3:EH-GV工程菌株的PCR结果;Figure 4 is a PCR identification of EH-GV of the present invention; wherein, M: DL2000 marker; 1: EHA105 no-load PCR result; 2-3: PCR result of EH-GV engineering strain;
图5是本发明农杆菌EH-GV转化合子胚来源的体细胞胚获得再生植株,其中,D-1:农杆菌侵染后的体细胞胚,D-2:农杆菌转化体细胞胚后萌发的抗性芽,D-3:农杆菌转化体细胞胚后生根的再生植株,D-4:温室移栽成活的转基因植株。Figure 5 is a regenerated plant of the somatic embryo derived from the Agrobacterium EH-GV transformed zygotic embryo of the present invention, wherein D-1: somatic embryo after infection by Agrobacterium, D-2: post-embryonic germination of Agrobacterium transformant cells Resistant bud, D-3: Regenerated plant of post-embryo rooting of Agrobacterium tumefaciens cells, D-4: Transgenic plants transplanted into the greenhouse.
具体实施方式detailed description
下面结合具体实施方式对本发明进行详细说明。The present invention will be described in detail below in conjunction with specific embodiments.
实施例1 通过无核葡萄品种间杂交和胚挽救获得带无核基因的葡萄合子胚:Example 1 Obtaining a grape zygotic embryo with a non-nuclear gene by hybridization and embryo rescue between seedless grape varieties:
步骤A-1、开花前3天对母本品种进行人工去雄(本实施例中母本品种为“红脸无核”),去雄后的花序立即用清水喷洗干净并套袋、挂牌标记;Step A-1, artificial emasculation of the female cultivar 3 days before flowering (the female parent in this example is “red-faced non-nuclear”), and the inflorescences after emasculation are immediately sprayed with water and bagged and tagged. ;
步骤A-2、去雄后第2-3天用毛笔蘸取父本花粉(本实施例中父本品种为“火焰无核”)散落在母本柱头上进行人工授粉;Step A-2. On the 2-3rd day after emasculation, the father's pollen is taken with a writing brush (in this embodiment, the male parent is "flame without nuclear") scattered on the female stigma for artificial pollination;
步骤A-3、授粉后6周田间采集幼果,自来水冲洗10min;在超净工作台上用70%的酒精浸泡1分钟后,再用0.1%的HgCl2浸泡消毒8分钟,无菌水漂洗4次;Step A-3, 6 weeks after pollination, collect young fruit in the field, rinse with tap water for 10 minutes; soak it in 70% alcohol for 1 minute on the ultra-clean workbench, then soak it in 0.1% HgCl 2 for 8 minutes, rinse with sterile water. 4 times;
步骤A-4、消毒后的果粒置于灭过菌的培养皿中,无菌条件下取出胚珠,接种在合子胚发育培养基上进行胚珠内胚培养,合子胚发育培养基为固液双相的TL培养基,其组分和含量如下:硝酸钙250.0mg/L,硝酸钾600.0mg/L,氯化钾75.0mg/L,硝酸铵300.0mg/L,硫酸镁1200.0mg/L,磷酸二氢钾300.0mg/L,硫酸锰3.0mg/L,碘化钾0.8mg/L, 硼酸0.5mg/L,硫酸锌0.5mg/L,亚硒酸钠0.25mg/L,氯化钴0.025mg/L,硫酸铜0.025mg/L,钼酸钠0.025mg/L,柠檬酸铁10.0mg/L,盐酸硫胺素0.25mg/L,盐酸吡哆辛0.25mg/L,D-泛酸钙0.25mg/L,烟酸0.25mg/L,天冬酰胺300mg/L,甘氨酸5.0mg/L,精氨酸2.0mg/L,肌醇50.0mg/L,水解酪蛋白500.0mg/L,L-半胱氨酸121.16mg/L,蔗糖30000mg/L,琼脂6000mg/L,其余为蒸馏水,其中附加蔗糖6.0g/L,活性炭1.5g/L;Step A-4, the disinfected fruit pieces are placed in a sterile culture dish, and the ovules are taken out under aseptic conditions, and inoculated on the zygotic embryo development medium for ovule endogenous culture, and the zygote embryo development medium is solid-liquid double Phase TL medium, its composition and content are as follows: calcium nitrate 250.0mg / L, potassium nitrate 600.0mg / L, potassium chloride 75.0mg / L, ammonium nitrate 300.0mg / L, magnesium sulfate 1200.0mg / L, phosphoric acid Potassium dihydrogen 300.0mg / L, manganese sulfate 3.0mg / L, potassium iodide 0.8mg / L, Boric acid 0.5mg/L, zinc sulfate 0.5mg/L, sodium selenite 0.25mg/L, cobalt chloride 0.025mg/L, copper sulfate 0.025mg/L, sodium molybdate 0.025mg/L, ferric citrate 10.0mg /L, thiamine hydrochloride 0.25mg / L, pyridoxine hydrochloride 0.25mg / L, D - calcium pantothenate 0.25mg / L, niacin 0.25mg / L, asparagine 300mg / L, glycine 5.0mg / L, Arginine 2.0mg/L, inositol 50.0mg/L, hydrolyzed casein 500.0mg/L, L-cysteine 121.16mg/L, sucrose 30000mg/L, agar 6000mg/L, the rest is distilled water, which is attached Sucrose 6.0g / L, activated carbon 1.5g / L;
步骤A-5、胚珠在合子胚发育培养基上培养6周后,无菌条件下取出发育的幼胚,接种在固体的胚性愈伤组织诱导培养基上,胚性愈伤组织诱导培养基的成分为TL+0.5mg/L6-BA+1.0mg/L 2,4-D,其中附加蔗糖30g/L,琼脂6.0g/L;即可获得带无核基因(比率在80%以上)的葡萄合子胚。Step A-5, after the ovule is cultured on the zygotic embryo development medium for 6 weeks, the developing immature embryos are taken out under aseptic conditions, and inoculated on the solid embryogenic callus induction medium, the embryogenic callus induction medium. The composition is TL+0.5mg/L6-BA+1.0mg/L 2,4-D, with 30g/L of sucrose and 6.0g/L of agar; the gene with no nuclear gene (the ratio is above 80%) can be obtained. Grape zygotic embryo.
实施例2 通过合子胚诱导发生体细胞胚Example 2 Induction of somatic embryos by zygotic embryo induction
步骤B-1、将步骤A获得的杂交合子胚接种在固体的胚性愈伤组织诱导培养基上,胚性愈伤组织诱导培养基的成分为TL+0.5mg/L 6-BA+1.0mg/L 2,4-D,其中附加蔗糖30g/L,琼脂6.0g/L;Step B-1, the hybrid zygotic embryo obtained in the step A is inoculated on the solid embryogenic callus induction medium, and the composition of the embryogenic callus induction medium is TL+0.5 mg/L 6-BA+1.0 mg. /L 2,4-D, wherein sucrose 30g / L, agar 6.0g / L;
步骤B-2、合子胚在胚性愈伤组织诱导培养基上培养4周后,将获得的黄色、颗粒状、发育紧实的胚性愈伤组织接种在固体的体细胞胚分化培养基上,体细胞胚分化培养基的成分为TL+0.5mg/L 6-BA+2.0mg/L NAA,其中,附加蔗糖30g/L,琼脂6.0g/L;Step B-2: After the zygotic embryo is cultured on the embryogenic callus induction medium for 4 weeks, the obtained yellow, granular, and compact embryogenic callus is inoculated on the solid somatic embryo differentiation medium. The composition of the somatic embryo differentiation medium is TL+0.5 mg/L 6-BA+2.0 mg/L NAA, wherein 30 g/L of sucrose and 6.0 g/L of agar are added;
步骤B-3、胚性愈伤组织在体细胞胚分化培养基上培养4周后,即可诱导获得大量的体细胞胚,本实施例中此时多数体细胞胚发育时期处在子叶型期。Step B-3, after the embryogenic callus is cultured on the somatic embryo differentiation medium for 4 weeks, a large number of somatic embryos can be induced. In this embodiment, most of the somatic embryo development stages are in the cotyledon stage. .
实施例3 构建RNAi抗病毒植物表达载体并转入根癌农杆菌Example 3 Construction of RNAi antiviral plant expression vector and transfer into Agrobacterium tumefaciens
步骤C-1(入门克隆载体的构建过程)、在本实施例中,RNAi干扰片段GV是GFLV、GLRaV-3、GVA和GVB 4个葡萄病毒外壳蛋白基因的保守区段顺序串联后获得的825bp的大片段(序列见SEQ ID NO.1)。用添加接头CACC的GV上游引物GV-F(引物序列为CACCATGGGTGATGAGCTTTGATGC,序列见SEQ ID NO.2)和下游引物GV-R(引物序列为TAGACTCTCAAGCTTGCTAA,序列见SEQ ID NO.3)进行PCR扩增,本实施例中PCR反应体系为:10×Buffer 5μL,dNTP mixtuer(2.5mM of each dNTP)5μL,GV-F(10μmol/L)2μL,GV-R(10μmol/L)2μL,Pfu DNA Polymerase 1μL,模板1μL,灭菌双蒸水34μL,总体积50μL。PCR反应参数为:94℃预变性5min;(94℃变性30s,56℃退火30s,72℃延伸40s)35个循环;72℃延伸10min。PCR产物经1.0%的琼脂糖凝胶电泳后目标条带切胶回收,获得含干扰片段(GV)的平末端PCR产物。按照pENTRTM/SD/
Figure PCTCN2015000519-appb-000002
试剂盒说明书,构建6μL反应体系,本实施例所用反应体系为: 回收目的基因片段GV 1μL,salt solution 1μL,pENTRTM/SD/
Figure PCTCN2015000519-appb-000003
vector 1μL,灭菌超纯水3μL),25℃条件下反应30min,连接产物热激法转化大肠杆菌Top10感受态细胞,均匀涂布在含75mg/L卡那霉素的LB固体培养基平板上,37℃倒置培养16h,挑单克隆到含有相同浓度Kan的LB液体培养基中37℃震荡培养14h,分别以GV-F&GV-R和M13-F(GTAAAACGACGGCCAGT,序列见SEQ ID NO.4)&GV-R两对引物,进行菌液PCR扩增,PCR产物经1.0%的琼脂糖凝胶电泳。本实施例中PCR反应体系为:10×Buffer 2μL,dNTP mixtuer(2.5mM ofeach dNTP)1.6μL,引物(10μmol/L)1μL各1μL,rTaq DNA Polymerase 0.2μL,模板1μL,灭菌双蒸水13.2μL,总体积20μL。PCR反应参数同步骤C-1。在以GV-F和GV-R作引物时,扩增产物如果出现829bp(825+4个碱基CACC=829bp)大小的目标条带(GV的长度为825bp),而以引物M13-F和GV-R为引物时,扩增片段的长度明显大于插入片段GV的长度,说明串联基因片段GV已连接进入pENTR/SD/D-TOPO载体,则被认定为构建好的入门克隆载体,在本实施例中命名为pENTR-GV(图1)。
Step C-1 (the construction process of the entry cloning vector), in the present embodiment, the RNAi interference fragment GV is 825 bp obtained by sequentially concatenating the conserved segments of the four grape virus coat protein genes of GFLV, GLRaV-3, GVA and GVB. Large fragment (see SEQ ID NO. 1 for the sequence). PCR amplification was carried out using the GV upstream primer GV-F (the primer sequence is CACCATGGGTGATGAGCTTTGATGC, the sequence is shown in SEQ ID NO. 2) and the downstream primer GV-R (the primer sequence is TAGACTCTCAAGCTTGCTAA, the sequence is shown in SEQ ID NO. 3). The PCR reaction system in this example is: 10×Buffer 5 μL, dNTP mixtuer (2.5 mM of each dNTP) 5 μL, GV-F (10 μmol/L) 2 μL, GV-R (10 μmol/L) 2 μL, Pfu DNA Polymerase 1 μL, 1 μL of template, sterile double distilled water 34 μL, total volume 50 μL. The PCR reaction parameters were: pre-denaturation at 94 ° C for 5 min; (degeneration at 94 ° C for 30 s, annealing at 56 ° C for 30 s, extension at 72 ° C for 40 s) for 35 cycles; 72 ° C for 10 min. The PCR product was subjected to 1.0% agarose gel electrophoresis and the target strip was recovered to obtain a blunt-end PCR product containing the interference fragment (GV). Follow pENTR TM /SD/
Figure PCTCN2015000519-appb-000002
The kit instructions were used to construct a 6 μL reaction system. The reaction system used in this example was: Recovering the target gene fragment GV 1 μL, salt solution 1 μL, pENTR TM /SD/
Figure PCTCN2015000519-appb-000003
Vector 1μL, sterile ultrapure water 3μL), reacted at 25°C for 30min, and the product was heat-induced to transform E. coli Top10 competent cells and evenly coated on LB solid medium plate containing 75mg/L kanamycin. Incubate at 37 ° C for 16 h, select monoclonal to LB liquid medium containing the same concentration of Kan in 37 ° C shaking culture for 14 h, respectively, GV-F & GV-R and M13-F (GTAAAACGACGGCCAGT, sequence see SEQ ID NO. 4) & GV Two pairs of primers of -R were subjected to PCR amplification of the bacterial solution, and the PCR product was subjected to 1.0% agarose gel electrophoresis. The PCR reaction system in this example is: 10×Buffer 2 μL, dNTP mixtuer (2.5 mM of each dNTP) 1.6 μL, primer (10 μmol/L) 1 μL each 1 μL, rTaq DNA Polymerase 0.2 μL, template 1 μL, sterile double distilled water 13.2 μL, total volume 20 μL. The PCR reaction parameters are the same as in step C-1. When GV-F and GV-R were used as primers, the amplified product showed a target band of 829 bp (825+4 bases CACC=829 bp) (GV was 825 bp in length), and primers M13-F and When GV-R is a primer, the length of the amplified fragment is significantly larger than the length of the inserted GV, indicating that the tandem gene fragment GV has been ligated into the pENTR/SD/D-TOPO vector, which is identified as a well-established cloning vector. In the examples, it was named pENTR-GV (Fig. 1).
步骤C-2RNAi载体的构建过程:将入门载体pENTR-GV和目标载体pHELLSGATE12进行LR反应,按照Gateway LR Clonase II Enzyme Mix剂盒说明书构建20μL反应体系,本实施例反应体系为:pENTR-GV 2μL,pHELLSGATE12,2μL,LR clonase enzyme mix 4μL,Sterile water 12μL。25℃条件下反应12h后,加入蛋白酶K终止反应。反应产物热激法转化大肠杆菌Top10感受态细胞,均匀涂布在含有100mg/L壮观霉素的LB培养基平板上,37℃倒置培养16h,挑单克隆到含相同浓度Spec的LB液体培养基中37℃震荡培养14h,提取质粒后用Xho I(图2)和Xba I(图3)进行单酶切(以pHELLSGATE12空载作对照),本实施例中Xba I酶切体系为:Xba I 1μL,10x M Buffer 2μL,0.1%BSA2μL,LR反应产物6μL,灭菌超纯水9μL;Xho I酶切体系为:Xho I 1μL,10x H Buffer 2μL,LR反应产物6μL,灭菌超纯水11μL。如果LR反应之后的重组质粒经Xho I和Xba I进行单酶切后切下片段大小约为900bp,且明显区别于未经反应的PHELLSGATE12空载切出的片段大小(Xho I切出片段为1429bp,Xba I切出片段为1419bp),则认定为则重组质粒为构建好的RNAi载体,在本实施例中命名为PH12-GV。Step C-2 RNAi vector construction process: The entry vector pENTR-GV and the target vector pHELLSGATE12 were subjected to LR reaction, and 20 μL reaction system was constructed according to the Gateway LR Clonase II Enzyme Mix kit instructions. The reaction system of this example was: pENTR-GV 2 μL, pHELLSGATE 12, 2 μL, LR clonase enzyme mix 4 μL, Sterile water 12 μL. After 12 h of reaction at 25 ° C, the reaction was stopped by the addition of proteinase K. The reaction product was heat-transformed into E. coli Top10 competent cells, uniformly coated on LB medium plate containing 100 mg/L spectinomycin, inverted culture at 37 ° C for 16 h, and picked up to LB liquid medium containing the same concentration of Spec. After incubating for 14 h at 37 ° C, the plasmid was extracted and then digested with Xho I (Fig. 2) and Xba I (Fig. 3) (with pHELLSGATE12 empty control as control). In this example, the Xba I digestion system was: Xba I 1μL, 10x M Buffer 2μL, 0.1% BSA2μL, LR reaction product 6μL, sterile ultrapure water 9μL; Xho I digestion system: Xho I 1μL, 10x H Buffer 2μL, LR reaction product 6μL, sterilized ultrapure water 11μL . If the recombinant plasmid after LR reaction was digested by Xho I and Xba I, the fragment size was about 900 bp, and the size of the fragment was significantly different from that of unreacted PHELLSGATE12 (Xho I was 1429 bp). The Xba I excised fragment was 1419 bp), and it was confirmed that the recombinant plasmid was a constructed RNAi vector, which was named PH12-GV in this example.
步骤C-3(RNAi载体转化根癌农杆菌过程)、将PH12-GV载体转化农杆菌菌株EHA105感受态细胞,均匀涂布在含有50mg/L利福平和100mg/L壮观霉素的YEB平板培养基上,28℃条件下倒置培养48h,挑单克隆到含有相同浓度的利福平和壮观霉素的YEB液体培养基中28℃震荡培养48h,用GV-F&GV-R作引物进行菌液PCR扩增, 1.0%琼脂糖凝胶电泳,PCR反应体系和反应参数同步骤C-1,如果出现829bp大小(825+4个碱基CACC=829bp)的片段(图4),则认定为RNAi植物表达载体工程菌株已经转化好,在本实施例中命名为EH-GV。Step C-3 (RNAi vector transformation of Agrobacterium tumefaciens), transforming PH12-GV vector into Agrobacterium strain EHA105 competent cells, uniformly coated on YEB plate containing 50 mg/L rifampicin and 100 mg/L spectinomycin On the base, incubate at 48 °C for 48 h, pick the monoclonal to the same concentration of rifampicin and spectinomycin in YEB liquid medium for 28 h at 28 °C, and use GV-F&GV-R as primer to carry out bacterial PCR amplification. Increase, 1.0% agarose gel electrophoresis, PCR reaction system and reaction parameters are the same as step C-1. If a fragment of 829 bp (825+4 bases CACC=829 bp) appears (Fig. 4), it is identified as RNAi plant expression vector engineering. The strain has been transformed, and is named EH-GV in this embodiment.
实施例4 农杆菌转化合子胚来源的体细胞胚获得再生植株Example 4 Agrobacterium transforms zygotic embryo-derived somatic embryos to obtain regenerated plants
步骤D-1、28℃、200rpm条件下,将转化农杆菌后的RNAi植物表达载体工程菌株EH-GV在含有50mg/L利福平的YEB液体培养基中震荡培养48小时,至OD值约为0.5,5000rpm离心10分钟后收集沉淀的菌体,用等体积的WPM液体培养基重悬,将步骤B-3获得的体细胞胚用农杆菌菌液浸泡侵染10-15分钟。Step D-1, 28 ° C, 200 rpm, the RNAi plant expression vector engineering strain EH-GV transformed with Agrobacterium was shake cultured in YEB liquid medium containing 50 mg/L rifampicin for 48 hours until the OD value was about After centrifugation at 0.5, 5000 rpm for 10 minutes, the precipitated cells were collected, resuspended in an equal volume of WPM liquid medium, and the somatic embryos obtained in the step B-3 were inoculated with Agrobacterium liquid for 10-15 minutes.
步骤D-2、侵染后的体细胞胚置于灭过菌的培养皿中,用灭过菌的滤纸吸干多余菌液,接种在WPM固体培养基上,黑暗条件下培养3天。Step D-2, the infected somatic embryos are placed in a sterile culture dish, and the excess bacterial solution is blotted with the sterilized filter paper, inoculated on a WPM solid medium, and cultured for 3 days in the dark.
步骤D-3、之后将侵染后的体细胞胚接种在WPM+0.2mg/L6-BA+50mg/L卡那霉素(Kan)+200mg/L头孢霉素(Cef)+200mg/L羧苄青霉素(Carb)培养基上,在16h/8h光周期条件下培养3个月,每2周继代一次。Step D-3, after inoculation of the infected somatic embryos in WPM + 0.2 mg / L 6 - BA + 50 mg / L kanamycin (Kan) + 200 mg / L cephalosporin (Cef) + 200 mg / L carboxy The cells were cultured on benzylpenicillin (Carb) medium for 3 months under the conditions of 16 h/8 h photoperiod, and subcultured every 2 weeks.
步骤D-4、将萌发获得的抗性芽培养在1/2MS+0.2mg/L吲哚丁酸(IBA)+25mg/L卡那霉素(Kan)+200mg/L Cef+200mg/LCarb培养基上,在16h/8h光周期条件下培养2个月,每4周继代一次,生根后的试管苗在1/2MS+0.2mg/L IBA+25mg/L Kan+200mg/L Cef+200mg/LCarb培养基上扩大培养后,选择生长健壮、生根良好的再生植株在温室内进行炼苗和移栽,具体为:将离体条件下根系发育良好的植株经温室炼苗后用清水洗净其上附着的琼脂,移栽入装有营养土的营养钵内,成活后的幼苗进行常规管理,发育成健壮的葡萄植株。Step D-4, culturing the resistant bud obtained by germination in 1/2MS+0.2mg/L indolebutyric acid (IBA)+25mg/L kanamycin (Kan)+200mg/L Cef+200mg/L Carb culture On the base, cultured for 2 months under the photoperiod of 16h/8h, once every 4 weeks, the test tube seedlings after rooting were 1/2MS+0.2mg/L IBA+25mg/L Kan+200mg/L Cef+200mg/LCarb After expanding the culture on the medium, the regenerated plants with strong growth and good rooting are selected for refining and transplanting in the greenhouse. Specifically, the plants with good root development under in vitro conditions are washed with water after being reheated in the greenhouse. The attached agar is transplanted into a nutrient bowl containing nutrient soil, and the lived seedlings are routinely managed to develop into a robust grape plant.
实施例5 转基因葡萄的抗病毒特性的鉴定Example 5 Identification of Antiviral Characteristics of Transgenic Grapes
步骤E-1、从田间上发病植株的葡萄病叶,用10倍体积0.05mmol/L磷酸缓冲液(pH=7.2)充分研磨,4000rpm离心10分钟,取上清液作为病毒提取物。Step E-1, the grape diseased leaves of the diseased plants in the field were thoroughly ground with 10 volumes of 0.05 mmol/L phosphate buffer (pH = 7.2), centrifuged at 4000 rpm for 10 minutes, and the supernatant was taken as a virus extract.
步骤E-2、用70%酒精对叶片进行表面消毒后充分晾干,用石英砂摩擦叶片上表面制造轻微伤口后,用手指蘸取病毒提取物,摩擦接种至葡萄幼嫩叶片,每个单株接种5个叶片,同时接种未转化的植株作对照,20天后进行植株带毒的DAS-ELISA检测。Step E-2. After surface disinfection of the leaves with 70% alcohol, dry them thoroughly. After rubbing the upper surface of the leaves with quartz sand to make a slight wound, use the fingers to pick up the virus extract and inoculate the seeds into the young leaves of the grapes. The plants were inoculated with 5 leaves, and the untransformed plants were inoculated as a control. After 20 days, the plants were tested with DAS-ELISA.
步骤E-3、取供试植株顶部叶片100mg,于1m L PBS缓冲液中研磨,离心后取上清,用0.1mol/L(pH 9.6)的碳酸盐包被缓冲液将抗体稀释成1g/m L包被EL ISA板,每孔100uL,37℃孵育4h;用PBST缓冲液洗板3次拍干加入病毒汁液每孔100uL,4℃过夜;用PBST洗板3次拍干加入1/4000稀释的共轭酶标抗体每孔100uL,37℃ 孵育3h;用PBST洗板4次,拍干,每孔加底物100uL,1h后在405nm波长下读取吸光值(OD405)。以脱毒试管苗“红宝石无核”为阴性对照,如果某植株读取的吸光值与阴性对照吸光值之比大于2.5则为阳性反应(植株带毒),即被认定为感病反应,否则为阴性反应(植株不带毒),即被认定为抗病反应,鉴定结果见表1。Step E-3, take 100 mg of the top leaves of the test plants, grind in 1 ml of PBS buffer, centrifuge, and take the supernatant, and dilute the antibody to 1 g with 0.1 mol/L (pH 9.6) carbonate coating buffer. /m L coated with EL ISA plate, 100uL per well, incubate for 4h at 37°C; wash plate with PBST buffer for 3 times, add 100uL of virus juice per well, overnight at 4°C; wash plate with PBST for 3 times to dry and add 1/ The 4000 diluted conjugated antibody was incubated at 100 uL per well for 3 h at 37 ° C; the plate was washed 4 times with PBST, patted dry, 100 uL of substrate was added to each well, and the absorbance (OD 405 ) was read at 405 nm after 1 h. The virus-free tube seedling "ruby seedless" is used as a negative control. If the ratio of the absorbance of a plant read to the negative control absorbance is greater than 2.5, it is a positive reaction (plant poison), which is considered as a susceptibility reaction, otherwise For the negative reaction (plants without toxicity), it was identified as the disease resistance reaction, and the identification results are shown in Table 1.
表1 转基因植株病毒接种后的抗病性反应鉴定Table 1 Identification of disease resistance after transgenic plant virus inoculation
Figure PCTCN2015000519-appb-000004
Figure PCTCN2015000519-appb-000004
表1结果可见,病毒接种后对照植株对4种病毒均表现为感病反应,而转化后获得的转基因植株多数情况下表现为抗病反应。在获得的4个转基因株系中,株系TrGV-1、TrGV-3、TrGV-4对葡萄生产中危害最为严重的4种病毒(GFLV、GLRaV-3、GVA、GVB)均表现为抗病反应;株系TrGV-2仅对病毒GVB表现为感病,而对其它3种病毒均表现为抗病反应。说明这些转基因植株在接种病毒后病毒积累量明显降低了,从而获得了抗病性的明显提高。 The results in Table 1 show that the control plants showed a susceptibility response to the four viruses after virus inoculation, and the transgenic plants obtained after transformation showed the disease resistance reaction in most cases. Among the four transgenic lines obtained, the strains TrGV-1, TrGV-3, and TrGV-4 showed the most serious four viruses (GFLV, GLRaV-3, GVA, GVB) in grape production. The reaction; the strain TrGV-2 showed only a disease for the virus GVB, but showed resistance to the other three viruses. It indicated that the virus accumulation of these transgenic plants was significantly reduced after inoculation of the virus, and thus the disease resistance was significantly improved.

Claims (10)

  1. 一种获得抗病毒无核葡萄的生物技术育种方法,其特征在于,包括以下步骤:A biotechnology breeding method for obtaining antiviral seedless grapes, characterized in that the method comprises the following steps:
    步骤1、通过无核葡萄品种间杂交和胚挽救获得带无核基因的葡萄合子胚;Step 1. Obtaining a grape zygotic embryo with a non-nuclear gene by crossing between the seedless grape varieties and embryo rescue;
    步骤2、通过合子胚诱导发生葡萄体细胞胚;Step 2. Inducing the growth of grape somatic embryos by zygotic embryos;
    步骤3、构建RNAi抗病毒植物表达载体并转入根癌农杆菌;Step 3. Construct an RNAi antiviral plant expression vector and transfer it to Agrobacterium tumefaciens;
    步骤4、农杆菌转化合子胚来源的体细胞胚获得再生植株。Step 4. Agrobacterium transforms the somatic embryo derived from the zygotic embryo to obtain a regenerated plant.
  2. 根据权利要求1所述的获得抗病毒无核葡萄的生物技术育种方法,其特征在于,所述步骤1中通过无核葡萄品种间杂交和胚挽救获得带无核基因的葡萄合子胚具体为:The method for breeding an antiviral seedless grape according to claim 1, wherein the grape zygotic embryo with the non-nuclear gene obtained by the hybridization between the seedless grape varieties and the embryo rescue in the step 1 is specifically:
    步骤1.1、开花前3天对母本品种进行人工去雄,去雄后的花序立即用清水喷洗干净并套袋、挂牌标记;Step 1.1: Artificial emasculation of the female parent species 3 days before flowering, the inflorescences after emasculation are immediately sprayed clean with water and bagged and tagged;
    步骤1.2、去雄后第2-3天用毛笔蘸取父本花粉散落在母本柱头上进行人工授粉;Step 1.2: On the 2-3rd day after the emasculation, the father's pollen is collected by the brush and scattered on the stigma of the female parent for artificial pollination;
    步骤1.3、授粉后6周田间采集幼果,自来水冲洗10min;在超净工作台上用70%的酒精浸泡1分钟后,再用0.1%的HgCl2浸泡消毒8分钟,无菌水漂洗4次;Step 1.3: After 6 weeks of pollination, the young fruit was collected in the field, rinsed with tap water for 10 min; soaked in 70% alcohol for 1 minute on the ultra-clean workbench, then immersed in 0.1% HgCl 2 for 8 minutes, rinsed 4 times with sterile water. ;
    步骤1.4、消毒后的果粒置于灭过菌的培养皿中,无菌条件下取出胚珠,接种在合子胚发育培养基上进行胚珠内胚培养,合子胚发育培养基为固液双相的TL培养基;Step 1.4: The sterilized fruit pieces are placed in a sterilized culture dish, and the ovules are taken out under aseptic conditions, and inoculated on the zygotic embryo development medium for ovule endogenous culture, and the zygotic embryo development medium is solid-liquid two-phase. TL medium;
    步骤1.5、胚珠在合子胚发育培养基上培养6周后,无菌条件下取出发育的幼胚,接种在固体的胚性愈伤组织诱导培养基上;即获得带无核基因的葡萄合子胚。Step 1.5: After the ovule is cultured on the zygotic embryo development medium for 6 weeks, the developing immature embryos are taken out under aseptic conditions, and inoculated on the solid embryogenic callus induction medium; that is, the grape zygotic embryo with the non-nuclear gene is obtained. .
  3. 根据权利要求2所述的获得抗病毒无核葡萄的生物技术育种方法,其特征在于,所述TL培养基的组分和含量如下:硝酸钙250.0mg/L,硝酸钾600.0mg/L,氯化钾75.0mg/L,硝酸铵300.0mg/L,硫酸镁1200.0mg/L,磷酸二氢钾300.0mg/L,硫酸锰3.0mg/L,碘化钾0.8mg/L,硼酸0.5mg/L,硫酸锌0.5mg/L,亚硒酸钠0.25mg/L,氯化钴0.025mg/L,硫酸铜0.025mg/L,钼酸钠0.025mg/L,柠檬酸铁10.0mg/L,盐酸硫胺素0.25mg/L,盐酸吡哆辛0.25mg/L,D-泛酸钙0.25mg/L,烟酸0.25mg/L,天冬酰胺300mg/L,甘氨酸5.0mg/L,精氨酸2.0mg/L,肌醇50.0mg/L,水解酪蛋白500.0mg/L,L-半胱氨酸121.16mg/L,蔗糖30000mg/L,琼脂6000mg/L,其余为蒸馏水,其中附加蔗糖6.0g/L,活性炭1.5g/L;步骤1.5中诱导培养基为:胚性愈伤组织诱导培养基的成分为TL+0.5mg/L6-BA+1.0mg/L 2,4-D,其中附加蔗糖30g/L,琼脂6.0g/L。The method for breeding an antiviral seedless grape according to claim 2, wherein the composition and content of the TL medium are as follows: calcium nitrate 250.0 mg/L, potassium nitrate 600.0 mg/L, chlorine Potassium 75.0mg / L, ammonium nitrate 300.0mg / L, magnesium sulfate 1200.0mg / L, potassium dihydrogen phosphate 300.0mg / L, manganese sulfate 3.0mg / L, potassium iodide 0.8mg / L, boric acid 0.5mg / L, sulfuric acid Zinc 0.5mg/L, sodium selenite 0.25mg/L, cobalt chloride 0.025mg/L, copper sulfate 0.025mg/L, sodium molybdate 0.025mg/L, ferric citrate 10.0mg/L, thiamine hydrochloride 0.25mg/L, pyridoxine hydrochloride 0.25mg/L, D-pantothenate 0.25mg/L, niacin 0.25mg/L, asparagine 300mg/L, glycine 5.0mg/L, arginine 2.0mg/L , inositol 50.0mg / L, hydrolyzed casein 500.0mg / L, L-cysteine 121.16mg / L, sucrose 30000mg / L, agar 6000mg / L, the rest is distilled water, which added 6.0g / L sucrose, activated carbon 1.5g/L; the induction medium in step 1.5 is: the composition of the embryogenic callus induction medium is TL+0.5mg/L6-BA+1.0mg/L 2,4-D, and 30g/L of sucrose is added. Agar 6.0g/L.
  4. 根据权利要求2所述的获得抗病毒无核葡萄的生物技术育种方法,其特征在于,所述步骤2中通过合子胚诱导发生体细胞胚具体为:The method for breeding an antiviral seedless grape according to claim 2, wherein the somatic embryo induced by the zygotic embryo in the step 2 is specifically:
    步骤2.1、将步骤1获得的杂交合子胚接种在固体的胚性愈伤组织诱导培养基上; Step 2.1, inoculation of the hybrid zygotic embryo obtained in step 1 on a solid embryogenic callus induction medium;
    步骤2.2、合子胚在胚性愈伤组织诱导培养基上培养4周后,将获得的黄色、颗粒状、发育紧实的胚性愈伤组织接种在固体的体细胞胚分化培养基上;Step 2.2: After the zygotic embryo is cultured on the embryogenic callus induction medium for 4 weeks, the obtained yellow, granular, and compact embryogenic callus is inoculated on the solid somatic embryo differentiation medium;
    步骤2.3、胚性愈伤组织在体细胞胚分化培养基上培养4周后,即可诱导获得大量的体细胞胚,此时多数体细胞胚发育时期处在子叶型期。Step 2.3: After the embryogenic callus is cultured on the somatic embryo differentiation medium for 4 weeks, a large number of somatic embryos can be induced, and at this time, most somatic embryo development stages are in the cotyledon stage.
  5. 根据权利要求4所述的获得抗病毒无核葡萄的生物技术育种方法,其特征在于,所述步骤2.1中胚性愈伤组织诱导培养基的成分为TL+0.5mg/L6-BA+1.0mg/L 2,4-D,其中附加蔗糖30g/L,琼脂6.0g/L;所述步骤2.3中体细胞胚分化培养基的成分为TL+0.5mg/L 6-BA+2.0mg/L NAA,其中,附加蔗糖30g/L,琼脂6.0g/L。The method for breeding an antiviral seedless grape according to claim 4, wherein the component of the embryogenic callus induction medium in the step 2.1 is TL+0.5 mg/L6-BA+1.0 mg. /L 2,4-D, wherein sucrose 30g / L, agar 6.0g / L; the composition of the somatic embryo differentiation medium in step 2.3 is TL + 0.5mg / L 6-BA + 2.0mg / L NAA Among them, 30 g/L of sucrose and 6.0 g/L of agar were added.
  6. 根据权利要求4所述的获得抗病毒无核葡萄的生物技术育种方法,其特征在于,所述步骤3中构建RNAi抗病毒植物表达载体并转入根癌农杆菌具体为:The method for breeding an antiviral seedless grape according to claim 4, wherein the RNAi antiviral plant expression vector is constructed in the step 3 and transferred to the Agrobacterium tumefaciens:
    步骤3.1、构建入门克隆载体:RNAi干扰片段GV是GFLV、GLRaV-3、GVA和GVB 4个葡萄病毒外壳蛋白基因的保守区段顺序串联后获得的825bp的大片段,序列见SEQ ID NO.1;用添加接头CACC的GV上游引物GV-F和下游引物GV-R进行PCR扩增,PCR产物经1.0%的琼脂糖凝胶电泳后目标条带切胶回收,获得含干扰片段GV的平末端PCR产物;构建6μL连接反应体系,25℃条件下反应30min,连接产物热激法转化大肠杆菌Top10感受态细胞,均匀涂布在含75mg/L卡那霉素的LB固体培养基平板上,37℃倒置培养16h,挑单克隆到含有相同浓度Kan的LB液体培养基中37℃震荡培养14h,扩增片段的长度明显大于插入片段GV的长度,即构建好入门克隆载体;命名为pENTR-GV;Step 3.1: Construction of the entry cloning vector: The RNAi interference fragment GV is a large fragment of 825 bp obtained by sequential concatenation of the conserved segments of the four grape virus coat protein genes of GFLV, GLRaV-3, GVA and GVB, and the sequence is shown in SEQ ID NO. PCR amplification was carried out with the GV upstream primer GV-F and the downstream primer GV-R with the addition of the linker CACC. The PCR product was subjected to 1.0% agarose gel electrophoresis and the target strip was recovered to obtain a blunt end containing the interference fragment GV. The PCR product was constructed by constructing 6 μL of ligation reaction system, reacting at 25 ° C for 30 min, and transforming the product by heat shock method to transform E. coli Top10 competent cells, and uniformly coating on LB solid medium plate containing 75 mg/L kanamycin, 37 Incubate in °C for 16h, select monoclonal to LB liquid medium containing the same concentration of Kan in 37 °C shaking culture for 14h, the length of the amplified fragment is significantly larger than the length of the insert GV, that is, construct the entry cloning vector; named pENTR-GV ;
    步骤3.2、构建RNAi载体:将入门载体pENTR-GV和目标载体pHELLSGATE12进行LR反应,构建20μL LR反应体系;25℃条件下反应12h后,加入蛋白酶K终止反应;反应产物热激法转化大肠杆菌Top10感受态细胞,均匀涂布在含有100mg/L壮观霉素(Spec)的LB培养基平板上,37℃倒置培养16h,挑单克隆到含相同浓度Spec的LB液体培养基中37℃震荡培养14h,提取质粒后用Xho I和Xba I进行单酶切,以pHELLSGATE12空载作对照;LR反应之后的重组质粒经Xho I和Xba I进行单酶切后切下片段大小分别为917bp和915bp,且明显区别于未经反应的PHELLSGATE12空载切出的片段大小,其中,空载用Xho I切出片段为1429bp,空载用Xba I切出片段为1419bp,则重组质粒为构建好的RNAi载体,在命名为PH12-GV;Step 3.2: Construction of RNAi vector: LR reaction of the entry vector pENTR-GV and the target vector pHELLSGATE12 to construct a 20 μL LR reaction system; after reacting at 25 ° C for 12 h, the reaction was terminated by adding proteinase K; the reaction product was heat-transformed into E. coli Top10 Competent cells were uniformly coated on LB medium plates containing 100 mg/L spectinomycin (Spec), inverted culture at 37 ° C for 16 h, and monoclonal cloned into LB liquid medium containing the same concentration of Spec in shaking culture at 37 ° C for 14 h. After extracting the plasmid, the plasmid was digested with Xho I and Xba I, and the pHELLSGATE12 was used as a control. The recombinant plasmid after LR reaction was digested with Xho I and Xba I, and the fragment size was 917 bp and 915 bp, respectively. Significantly different from the fragment size of unreacted PHELLSGATE12, the fragment was 1429 bp in Xho I and 1419 bp in Xba I. The recombinant plasmid was constructed as RNAi vector. Named PH12-GV;
    步骤3.3、RNAi载体转化根癌农杆菌:将PH12-GV载体转化农杆菌菌株EHA105感受态细胞,均匀涂布在含有50mg/L利福平和100mg/L壮观霉素的YEB平板培养基上,28℃条件下倒置培养48h,挑单克隆到含有相同浓度的利福平和壮观霉素的YEB液 体培养基中28℃震荡培养48h,用GV-F和GV-R作引物进行菌液PCR扩增,1.0%琼脂糖凝胶电泳,PCR产物为829bp的片段,则RNAi植物表达载体工程菌株已转化好,命名为EH-GV。Step 3.3: RNAi vector transformation Agrobacterium tumefaciens: The PH12-GV vector was transformed into Agrobacterium strain EHA105 competent cells, and uniformly coated on YEB plate medium containing 50 mg/L rifampicin and 100 mg/L spectinomycin, 28 Inverted cultured for 48 h at °C, and picked the monoclonal to the YEB solution containing the same concentration of rifampicin and spectinomycin. The medium was shaken at 28 °C for 48 h, and GV-F and GV-R were used as primers for PCR amplification, 1.0% agarose gel electrophoresis, PCR product was 829 bp fragment, RNAi plant expression vector engineering strain Converted, named EH-GV.
  7. 根据权利要求6所述的获得抗病毒无核葡萄的生物技术育种方法,其特征在于,所述GV的上游引物GV-F的序列如SEQ ID NO.2所示,具体为:CACCATGGGTGATGAGCTTTGATGC;所述GV的下游引物的序列如SEQ ID NO.3所示,具体为:TAGACTCTCAAGCTTGCTAA;The method for obtaining an antiviral seedless grape according to claim 6, wherein the sequence of the upstream primer GV-F of the GV is as shown in SEQ ID NO. 2, specifically: CACCATGGGTGATGAGCTTTGATGC; The sequence of the downstream primer of GV is shown in SEQ ID NO. 3, specifically: TAGACTCTCAAGCTTGCTAA;
    所述步骤3.1和步骤3.3中的PCR反应体系为:10×Buffer 5μL,dNTP mixtuer 5μL,10μmol/L的GV-F2μL,10μmol/L的GV-R 2μL,Pfu DNA Polymerase 1μL,模板1μL,灭菌双蒸水34μL,总体积50μL;PCR反应参数为:94℃预变性5min;94℃变性30s,56℃退火30s,72℃延伸40s,共35个循环;72℃延伸10min;The PCR reaction system in the steps 3.1 and 3.3 is: 10×Buffer 5 μL, dNTP mixtuer 5 μL, 10 μmol/L GV-F 2 μL, 10 μmol/L GV-R 2 μL, Pfu DNA Polymerase 1 μL, template 1 μL, sterilization Double distilled water 34μL, total volume 50μL; PCR reaction parameters: pre-denaturation at 94 °C for 5min; denaturation at 94 °C for 30s, annealing at 56 °C for 30s, extension at 72 °C for 40s, a total of 35 cycles; 72 °C extension for 10min;
    所述M13-F的序列如SEQ ID NO.4所示,具体为:GTAAAACGACGGCCAGT。The sequence of the M13-F is shown in SEQ ID NO. 4, specifically: GTAAAACGACGGCCAGT.
    步骤3.1中所用连接反应体系为:回收目的基因片段GV 1μL,salt solution 1μL,
    Figure PCTCN2015000519-appb-100001
    vector 1μL,灭菌超纯水3μL。
    The ligation reaction system used in step 3.1 is: recovery of the target gene fragment GV 1 μL, salt solution 1 μL,
    Figure PCTCN2015000519-appb-100001
    Vector 1 μL, 3 μL of sterile ultrapure water.
  8. 根据权利要求6所述的获得抗病毒无核葡萄的生物技术育种方法,其特征在于,所述步骤3.2中的Xba I酶切体系为:Xba I 1μL,10xM Buffer 2μL,0.1%BSA 2μL,LR反应产物6μL,灭菌超纯水9μL;Xho I酶切体系为:Xho I 1μL,10xH Buffer 2μL,LR反应产物6μL,灭菌超纯水11μL。The method for breeding an antiviral seedless grape according to claim 6, wherein the Xba I digestion system in the step 3.2 is: Xba I 1 μL, 10×M Buffer 2 μL, 0.1% BSA 2 μL, LR 6 μL of the reaction product, 9 μL of sterilized ultrapure water; Xho I digestion system: Xho I 1 μL, 10×H Buffer 2 μL, LR reaction product 6 μL, and sterilized ultrapure water 11 μL.
  9. 根据权利要求6所述的获得抗病毒无核葡萄的生物技术育种方法,其特征在于,所述步骤3.2中的LR反应体系为:pENTR-GV 2μL,pHELLSGATE12,2μL,LR clonase enzyme mix 4μL;Sterile water 12μL。The method for breeding an antiviral seedless grape according to claim 6, wherein the LR reaction system in the step 3.2 is: pENTR-GV 2 μL, pHELLSGATE 12, 2 μL, LR clonase enzyme mix 4 μL; Sterile Water 12μL.
  10. 根据权利要求6所述的获得抗病毒无核葡萄的生物技术育种方法,其特征在于,所述步骤4中农杆菌转化合子胚来源的体细胞胚获得再生植株具体为:The method for breeding an antiviral seedless grape according to claim 6, wherein in the step 4, the Agrobacterium-derived zygotic embryo-derived somatic embryo obtains the regenerated plant:
    步骤4.1、28℃、200rpm条件下,将转化农杆菌后的RNAi植物表达载体工程菌株EH-GV在含有50mg/L利福平的YEB液体培养基中震荡培养48小时,至OD值约为0.5,5000rpm离心10分钟后收集沉淀的菌体,用等体积的WPM液体培养基重悬,将步骤2.3获得的体细胞胚用农杆菌菌液浸泡侵染10-15分钟;Step 4.1, at 28 ° C, 200 rpm, the RNAi plant expression vector engineering strain EH-GV transformed with Agrobacterium was shake cultured in YEB liquid medium containing 50 mg/L rifampicin for 48 hours until the OD value was about 0.5. After centrifugation at 5000 rpm for 10 minutes, the precipitated cells were collected, resuspended in an equal volume of WPM liquid medium, and the somatic embryo obtained in step 2.3 was inoculated with Agrobacterium liquid for 10-15 minutes;
    步骤4.2、侵染后的体细胞胚置于灭过菌的培养皿中,用灭过菌的滤纸吸干多余菌液,接种在WPM固体培养基上,黑暗条件下培养3天;Step 4.2: The infected somatic embryo is placed in a sterile culture dish, and the excess bacterial solution is blotted with the sterile filter paper, inoculated on the WPM solid medium, and cultured for 3 days in the dark;
    步骤4.3、之后将侵染后的体细胞胚接种在WPM+0.2mg/L6-BA+50mg/L卡那霉素 (Kan)+200mg/L头孢霉素(Cef)+200mg/L羧苄青霉素(Carb)培养基上,在16h/8h光周期条件下培养3个月,每2周继代一次;Step 4.3, after inoculation of the infected somatic embryos in WPM + 0.2 mg / L 6-BA + 50 mg / L kanamycin (Kan) + 200 mg / L cephalosporin (Cef) + 200 mg / L carbenicillin (Carb) medium, cultured for 16 months under the conditions of 16h / 8h photoperiod, once every 2 weeks;
    步骤4.4、将萌发获得的抗性芽培养在1/2MS+0.2mg/L吲哚丁酸(IBA)+25mg/L Kan+200mg/L Cef+200mg/LCarb培养基上,在16h/8h光周期条件下培养2个月,每4周继代一次,生根后的试管苗在1/2MS+0.2mg/L IBA+25mg/L Kan+200mg/L Cef+200mg/LCarb培养基上扩大培养后,选择生长健壮、生根良好的再生植株在温室内进行炼苗和移栽,制备得到抗病毒无核葡萄。 Step 4.4, cultivating the resistant bud obtained by germination on 1/2MS+0.2mg/L 吲哚butyric acid (IBA)+25mg/L Kan+200mg/L Cef+200mg/L Carb medium at 16h/8h light Incubate for 2 months under cyclic conditions, subculture every 4 weeks, and the tube seedlings after rooting are expanded on 1/2MS+0.2mg/L IBA+25mg/L Kan+200mg/L Cef+200mg/L Carb medium. Regenerated plants with strong growth and good rooting are cultivated and transplanted in the greenhouse to prepare antiviral seedless grapes.
PCT/CN2015/000519 2015-06-30 2015-08-12 Biotechnological breeding method for obtaining antiviral seedless grapes WO2017000089A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201510377125.0 2015-06-30
CN201510377125.0A CN104988179A (en) 2015-06-30 2015-06-30 Biotechnological breeding method for obtaining antiviral seedless grapes

Publications (1)

Publication Number Publication Date
WO2017000089A1 true WO2017000089A1 (en) 2017-01-05

Family

ID=54300073

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2015/000519 WO2017000089A1 (en) 2015-06-30 2015-08-12 Biotechnological breeding method for obtaining antiviral seedless grapes

Country Status (2)

Country Link
CN (1) CN104988179A (en)
WO (1) WO2017000089A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111909953A (en) * 2020-06-05 2020-11-10 东北林业大学 Recombinant vector for genetic expression of phellinus igniarius, construction method and genetic transformation method
CN114686492A (en) * 2020-12-31 2022-07-01 哈尔滨师范大学 Application of MsbHLH115 gene of alfalfa and recombinant vector containing MsbHLH115 gene
CN115211370A (en) * 2022-08-18 2022-10-21 西北农林科技大学 Cabernet sauvignon flower organ callus induction culture medium and culture method

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109906868A (en) * 2019-04-03 2019-06-21 新疆农业科学院园艺作物研究所 A kind of method of new grape variety quickly breeding
CN109880833A (en) * 2019-04-19 2019-06-14 西北农林科技大学 The gene of Seed Development can be effectively reduced and its cultivating the application in seedless plant
CN111733171B (en) * 2020-06-23 2022-02-25 中国农业科学院郑州果树研究所 Target gene segment for resisting root cancer, interference vector and application thereof
CN112126646B (en) * 2020-09-28 2022-07-19 西北农林科技大学 sgRNA, vector, host cell and method for resisting grape leaf curl virus-3 of plant

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1415189A (en) * 2002-08-05 2003-05-07 西北农林科技大学 Method for high performance collective breeding non-nuclear grape with disease resistant capability
CN1896227A (en) * 2006-06-26 2007-01-17 西北农林科技大学 Double-phase culture-medium for improving antiviral and nuclease-free grape-embryo crash breeding efficiency and its production
CN101564011A (en) * 2009-05-18 2009-10-28 杭州蓝天园林建设集团有限公司余杭分公司 High-efficient breeding technique of Eurasian raisin grape
CN101982065A (en) * 2010-09-07 2011-03-02 河北科技师范学院 Method for simplifying saving of seedless grape embryo
CN103181321A (en) * 2013-03-07 2013-07-03 西北农林科技大学 Breeding method for cold-resistant seedless grape

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1415189A (en) * 2002-08-05 2003-05-07 西北农林科技大学 Method for high performance collective breeding non-nuclear grape with disease resistant capability
CN1896227A (en) * 2006-06-26 2007-01-17 西北农林科技大学 Double-phase culture-medium for improving antiviral and nuclease-free grape-embryo crash breeding efficiency and its production
CN101564011A (en) * 2009-05-18 2009-10-28 杭州蓝天园林建设集团有限公司余杭分公司 High-efficient breeding technique of Eurasian raisin grape
CN101982065A (en) * 2010-09-07 2011-03-02 河北科技师范学院 Method for simplifying saving of seedless grape embryo
CN103181321A (en) * 2013-03-07 2013-07-03 西北农林科技大学 Breeding method for cold-resistant seedless grape

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TIAN, LILI ET AL.: "Construction of Binary RNAi Expression Vector with Virus Resistance and Genetic Transformation in Tobacco", JOURNAL OF FRUIT SCIENCE, vol. 29, no. 6, 31 December 2012 (2012-12-31) *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111909953A (en) * 2020-06-05 2020-11-10 东北林业大学 Recombinant vector for genetic expression of phellinus igniarius, construction method and genetic transformation method
CN111909953B (en) * 2020-06-05 2023-07-07 东北林业大学 Recombinant vector for Phellinus linteus genetic expression, construction method and genetic transformation method
CN114686492A (en) * 2020-12-31 2022-07-01 哈尔滨师范大学 Application of MsbHLH115 gene of alfalfa and recombinant vector containing MsbHLH115 gene
CN114686492B (en) * 2020-12-31 2023-08-01 哈尔滨师范大学 Application of MsbHLH115 gene of alfalfa and recombinant vector containing MsbHLH115 gene
CN115211370A (en) * 2022-08-18 2022-10-21 西北农林科技大学 Cabernet sauvignon flower organ callus induction culture medium and culture method
CN115211370B (en) * 2022-08-18 2023-09-01 西北农林科技大学 Cabernet sauvignon flower organ callus induction medium and culture method

Also Published As

Publication number Publication date
CN104988179A (en) 2015-10-21

Similar Documents

Publication Publication Date Title
WO2017000089A1 (en) Biotechnological breeding method for obtaining antiviral seedless grapes
Ellul et al. The expression of the Saccharomyces cerevisiae HAL1 gene increases salt tolerance in transgenic watermelon [Citrullus lanatus (Thunb.) Matsun. & Nakai.]
Lee et al. Transgenic peppers that are highly tolerant to a new CMV pathotype
CN105543269B (en) Plant is improved to the method for resistance to verticillium wilt using beauveria bassiana BbP4-ATPase gene
WO2017076306A1 (en) Method for improving plant resistance to verticillium wilt using verticillium-wilt bacteria vdp4-atpase gene
CN106480163B (en) A method of joint apple callus cell culture and genetic transformation identify apple disease-resistant gene
Krastanova et al. Resistance to crown gall disease in transgenic grapevine rootstocks containing truncated virE2 of Agrobacterium
CN105624170A (en) Application of OsAGO18 protein or encoding gene of OsAGO18 protein to regulation and control on resistance of plants on RDV (Rice Dwarf Virus) or virus in same family as RDV
CN102676564A (en) Method enabling scion variety to obtain virus resistance, RNA (ribonucleic acid) interference vector and transgenosis method
CN105647961A (en) Application of rice gene BSK331 in improvement of plant stress tolerance
Kumari et al. PRSV resistance in papaya (Carica papaya L.) through genetic engineering: A review.
WO2021131628A1 (en) Solanaceous plant and solanaceous plant cell having resistance to tomato spotted wilt virus, and method for producing solanaceous plant
Korbin et al. Transformation of Gerbera plants with Tomato spotted wilt virus (TSWV) nucleoprotein gene
CN108277228A (en) A method of plant is improved to geminivirus infection resistance
Min et al. Pepper, chili (Capsicum annuum)
Burza et al. Cucumber (Cucumis sativus L.)
Krens et al. Oriental lily hybrids engineered to resist aphid attack
CN113584055B (en) Pepper PNPAL3 gene and application thereof in resisting blast of peppers
CN115896160B (en) Method for efficiently and rapidly obtaining apple stable transgenic plants by using agrobacterium rhizogenes
CN113755519B (en) Multi-antibody screening poplar polygene genetic transformation method
Damiano et al. Improving regeneration and transformation for resistance to sharka in Prunus
Raghunathachari et al. Agrobacterium mediated transformation of a pure line variety of hot pepper, RCL 59M
CN106244595A (en) Lignum seu Ramulus Cunninghamiae Lanceolatae phytosulfokine-α CLPSK1 gene and application thereof
Song Recent advances and opportunities in cherry biotechnology
CN105968178A (en) Application of rice OsRAD1 protein or encoding gene thereof in regulating pollen fertility

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15896621

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15896621

Country of ref document: EP

Kind code of ref document: A1